F 0558
Reasonably accommodate the needs and preferences of each resident.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to provide reasonable accommodation of
resident needs and preferences to two of three sampled residents (Resident 12 and 47) investigated during
review of environment facility task by failing to ensure the call light (an alerting device for nurses or other
nursing personnel to assist a resident when in need) was within residents' reach. This deficient practice had
the potential to result in Residents 12 and 47 not being able to call for facility staff assistance and delay in
the provision of necessary care and services that can negatively affect residents' comfort and well-being.
Findings: a. During a review of Resident 12's admission Record (AR), the AR indicated the facility admitted
Resident 12 on 1/26/2021 and readmitted on [DATE] with diagnoses including chronic obstructive
pulmonary disease (COPD-a chronic lung disease causing difficulty in breathing), diabetes mellitus (DM-a
disorder characterized by difficulty in blood sugar control and poor wound healing), and dementia (a
progressive state of decline in mental abilities). During a review of Resident 12's History and Physical
(H&P), dated 4/2/2025, the H&P indicated Resident 12 had impaired cognitive functioning ((mental
processes that enable people to think, understand, make decisions, and complete tasks). During a review
of Resident 12's Minimum Data Set (MDS-a resident assessment tool), dated 6/9/2025, the MDS indicated
Resident 12 had severely impaired cognitive functioning (mental processes that enable people to think,
understand, make decisions, and complete tasks). The MDS also indicated Resident 12 required maximal
assistance with oral hygiene, toileting hygiene, bathing, upper and lower body dressing. During a review of
Resident 12's Care Plan (CP), initiated on 4/12/2025, the CP indicated Resident 12 had activities of daily
living (ADLs - routine tasks/activities such as bathing, dressing and toileting a person performs daily to care
for themselves) related to bed mobility, transfer, walk in room, walk in corridor, locomotion in unit and off
unit, dressing, eating, toilet use, personal hygiene, bathing. The CP indicated Resident ADL needs will be
met daily with interventions to assist with ADL as needed. During a concurrent observation and interview
on 6/30/2025 at 8:57 a.m. with Certified Nurse Assistant (CNA) 2 inside Resident 12's room, Resident 12's
call light was observed behind the Resident's bed, away from Resident's reach. CNA 2 stated Resident 12
would not be able to reach the call light behind the bed and the call light should have been placed within
Resident 12's reach to make sure the resident can call for assistance during emergencies. During an
interview on 7/2/2025 at 10:15 a.m. with Registered Nurse (RN) 1, RN 1 stated call lights should be placed
within resident's reach. RN 1 stated failure to place the call light within the resident's reach could potentially
delay resident's care and cause accidents such as falls. During an interview on 7/3/2025 at 12:26 p.m. with
the Director of Nursing (DON), the DON stated residents use call light to call staff for assistance so the call
light should be placed within resident's reach. The DON stated the failure to place the call light within
resident's reach could potentially lead to delay of necessary care. b. During a review of Resident 47's
admission Record (AR), the AR indicated the facility
Residents Affected - Few
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 58
Event ID:
555132
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0558
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
admitted Resident 47 on 2/21/2023 and readmitted on [DATE] with diagnoses including congestive heart
failure (CHF-a heart disorder which causes the heart to not pump the blood efficiently, sometimes resulting
in leg swelling), chronic obstructive pulmonary disease (COPD-a chronic lung disease causing difficulty in
breathing), epilepsy (a sudden, uncontrolled electrical disturbances in the brain which can cause
uncontrolled jerking, blank stares and loss of consciousness), and depression (mental health illness
causing a persistent feeling of sadness, loss of interest, and can interfere with daily life). During a review of
Resident 47's MDS, dated [DATE], the MDS indicated Resident 47 had moderately impaired cognitive
functioning. The MDS also indicated Resident 47 required moderate assistance with toilet transfers, toilet
hygiene, showers, upper and lower body dressing, personal hygiene. During a concurrent observation and
interview on 6/30/2025 at 9:15 a.m. with CNA 3 inside Resident 47's room, Resident 47's call light was
observed behind Resident 47's bed away from Resident's reach. CNA 3 states Resident 47 could not reach
the call light behind the bed. CNA 3 stated the call light should be in a place where the resident can reach.
CNA 3 stated if the call light is not within residents' reach, then residents will not be able to call for help and
will not receive necessary help. During an interview on 7/2/2025 at 10:15 a.m. with Registered Nurse (RN)
1, RN 1 stated call lights should be placed within resident's reach. RN 1 stated failure to place the call light
within the resident's reach could potentially delay resident's care and cause accidents such as falls. During
a review of the facility-provided policy and procedure (P&P) titled, Answering the Call Light, last reviewed
on 01/2025, the P&P indicated, When the resident is in bed or confirmed to a chair be sure the call light is
within easy reach of the resident. Report all defective call lights to the nurse supervisor promptly.
Event ID:
Facility ID:
555132
If continuation sheet
Page 2 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0578
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Honor the resident's right to request, refuse, and/or discontinue treatment, to participate in or refuse to
participate in experimental research, and to formulate an advance directive.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure residents rights to formulate an Advance Directive
(AD, a legal document that outlines an individual's wishes regarding medical care in the event they become
incapacitated and unable to communicate their preferences) for three of five sampled residents (Resident
20, 219, and 119) reviewed under the AD care area by failing to provide written information concerning the
right to formulate an AD. This deficient practice had the potential to violate the residents' right to have their
wishes honored regarding health care decisions.
Findings:
a. During a review of Resident 20’s admission Record (AR), the AR indicated the facility originally
admitted the resident on 3/17/2025 and most recently re-admitted the resident on 5/1/2025 with diagnoses
that included End Stage Renal Disease (ESRD -irreversible kidney failure), type two diabetes mellitus
(DM-a disorder characterized by difficulty in blood sugar control and poor wound healing), unspecified
dementia (a general term for loss of memory, language, problem-solving and other thinking abilities that
interfere with daily life), and sepsis (a life-threatening blood infection).
During a review of Resident 20’s Minimum Data Set (MDS – resident assessment tool) dated
6/6/2025, the MDS indicated the resident was able to understand others and was able to make himself
understood. The MDS further indicated that the resident was dependent on staff for eating, bathing,
dressing, toileting, personal and oral hygiene, and transferring from the bed to chair.
During a review of Resident 20’s in progress (not completed) status Social Service History and
Initial Assessment Form, dated 6/13/2025, the form did not indicate if the resident had an AD or if the
resident or resident representative (RR) wanted information on advanced care planning.
During a concurrent interview and record review on 7/1/2025 at 12:22 p.m. with Licensed Vocational Nurse
(LVN) 2, LVN 2 reviewed Resident 20’s Physician Orders for Life-Sustaining Treatment (POLST
– a form that contains written medical orders for healthcare professionals regarding specific medical
treatments that can or cannot be done at the end-of life) dated 5/28/2025. LVN 2 stated the POLST
indicated an incomplete area for information regarding the AD, and did not indicate that the AD was
discussed with the resident or resident representative. LVN 2 stated the Social Services Director (SSD)
would have more information about the AD.
During a concurrent interview and record review on 7/2/2025 at 9:09 a.m. with the SSD, the SSD reviewed
Resident 20’s in progress Social Service History and Initial Assessment Form, dated 6/13/2025. The
SSD stated the AD is a document that gives information on a resident’s wishes regarding medical
decisions. The SSD stated the AD gives a resident representative the ability to make decisions if the
resident has a change of condition and can no longer make decisions for themselves. The SSD stated the
facility AD process is to speak with the resident or RR upon admission and ask if the resident has an AD or
if the resident would like to formulate an AD. The SSD stated written information is provided regarding the
resident’s right to formulate an AD and the AD Acknowledgment form should be signed by the
resident or RR. The SSD stated Resident 20 did not have a complete AD Acknowledgment form. The SSD
stated the Social Service History and Initial Assessment Form was not completed and there was no
documented evidence that the AD was discussed with Resident 20 or their RR. The SSD stated if there was
no documentation that information was discussed with the resident or
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 3 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0578
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
RR regarding the AD, then it was not done. The SSD stated the facility process was not followed for
Resident 20 and there was a potential for the resident’s wishes not being followed because the
facility was not aware of the resident’s wishes.
During an interview on 7/2/2025 at 11:25 a.m. with Registered Nurse (RN) 1, RN 1 stated upon admission
the AD Acknowledgment form should be completed to indicate a resident was given information regarding
the right to appoint another person as a decision maker when the resident is not able to make decisions for
themself. RN 1 stated the SSD or a nurse will follow up to obtain the AD as needed. RN 1 stated if the AD
Acknowledgment form is not completed it indicates the resident was not given information on the AD. RN 1
stated failing to provide information regarding the AD indicates a lack of communication between the
resident and facility that can potentially lead to the facility not following the resident’s wishes.
b. During a review of Resident 219’s AR, the AR indicated the facility admitted the resident on
6/18/2025 with diagnoses that included hemiplegia (total paralysis of the arm, leg, and trunk on the same
side of the body) and hemiparesis (partial paralysis or weakness on one side of the body) following
cerebrovascular infarction (CVA-stroke, loss of blood flow to a part of the brain) affecting the right dominant
side, and anxiety disorder (a mental health condition that may result in restlessness, irritability, feelings of
nervousness, panic, and fear).
During a review of Resident 219’s MDS dated [DATE], the MDS indicated the resident was able to
understand others and was able to make herself understood. The MDS further indicated that the resident
was dependent on staff for toileting, bathing, and lower body dressing; and required substantial / maximal
assistance for upper body dressing, personal hygiene, and transferring from the bed to chair.
During a review of Resident 219’s History and Physical (H&P), dated 6/19/2025, the H&P indicated
the resident had the capacity to understand and make decisions.
During an interview on 7/1/2025 at 12:22 p.m. with LVN 2, LVN 2 stated Resident 219 did not have an AD,
did not have a completed AD Acknowledgment form, and the SSD would have more information about the
AD.
During a concurrent interview and record review on 7/2/2025 at 9:09 a.m. with the SSD, the SSD reviewed
Resident 219’s Progress Notes dated 6/2025. The SSD stated the AD is a document that gives
information on a resident’s wishes regarding medical decisions. The SSD stated the AD gives a
resident representative the ability to make decisions if the resident has a change of condition and can no
longer make decisions for themself. The SSD stated the facility AD process is to speak with the resident or
RR upon admission and ask if the resident has an AD or if the resident would like to formulate an AD. The
SSD stated written information is provided regarding the resident’s right to formulate an AD and the
AD Acknowledgment form should be signed by the resident or RR. The SSD stated Resident 219 did not
have a complete AD Acknowledgment form. The SSD stated there was no documented evidence that the
AD was discussed with Resident 219. The SSD stated if there was no documentation that information was
discussed with the resident regarding the AD, then it was not done. The SSD stated the facility process was
not followed for Resident 219 and there was a potential for the resident’s wishes not being followed
because the facility was not aware of the resident’s wishes.
During an interview on 7/2/2025 at 11:25 a.m. with RN 1, RN 1 stated upon admission the AD
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 4 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0578
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Acknowledgment form should be completed to indicate a resident was given information regarding the right
to appoint another person as a decision maker when the resident is not able to make decisions for
themself. RN 1 stated the SSD or a nurse will follow up to obtain the AD as needed. RN 1 stated if the AD
Acknowledgment form is not completed it indicates the resident was not given information on the AD. RN 1
stated failing to provide information regarding the AD indicates a lack of communication between the
resident and facility that can potentially lead to the facility not following the resident’s wishes.
c. During a review of Resident 119’s AR, the AR indicated the facility admitted the resident on
5/27/2025 with diagnoses including anxiety disorder (feeling of anxiousness that affects daily life), bipolar
disorder (mood swings that range from the lows of depression to elevated periods of emotional highs),
neuropathy (disease or dysfunction of one or more nerves, typically causing numbness or weakness in the
hands and feet), and psychosis (a severe mental condition in which thought, and emotions are so affected
that contact is lost with reality).
During a review of Resident 119’s “H&P,” dated 5/27/2025, the “H&P”
indicated, Resident 1 had the capacity to understand and make decisions.
During a review of Resident 119’s MDS dated [DATE], the MDS indicated Resident 119’s
cognitive functioning (mental processes that enable people to think, understand, make decisions, and
complete tasks) was intact. The MDS further indicated that Resident 119 required moderate assistance with
upper body dressing, personal hygiene, bathing, and was dependent on lower body dressing, transferring
from the bed to chair and moving from lying to sitting position.
During a concurrent interview and record review on 7/2/2025 at 9:55a.m. with the SSD, Resident
119’s “Social Service Assessment and Initial History,” dated 5/28/25 was reviewed.
The record indicated the AD was not discussed with Resident 119. SSD stated Resident 119 did not have a
complete AD Acknowledgment form to indicate that Resident 119 was provided information on AD. The
SSD stated this failure had the potential for facility not to follow Resident 119’s wishes and
negatively affect Resident 119’s well-being.
During an interview on 7/2/2025 at 11:25 a.m. with Registered Nurse (RN) 1, RN 1 stated failing to provide
information regarding the AD indicated lack of communication between the resident and facility that could
potentially lead to the facility not following the resident’s wishes.
During a review of the facility provided Policy and Procedure (P&P) titled, “Advance
Directives,” last reviewed 1/2025, the P&P indicated Advance directives will be respected in
accordance with state law and facility policy. Prior to or upon admission of a resident to the facility, the
Social Services Director or designee will provide written information to the resident concerning his/her right
to make decisions concerning medical care. including the right to accept or refuse medical or surgical
treatment, and the right to formulate ADs. Prior to or upon the admission of a resident the Social Services
Director or designee will inquire of the resident, and/or his/her family members, about the existence of any
written advance directives. Information about whether or not the resident has executed an advance directive
shall be displayed prominently in the medical record. If the resident indicates that he or she has not
established advance directives, the facility staff will offer assistance in establishing advance directives. The
resident will be given the option to accept or decline the assistance, and care will not be contingent on
either decision. Nursing staff will document in the medical record the offer to assist and the resident's
decision to accept or decline. The plan of care for each resident will be consistent with his or her
documented treatment preferences
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 5 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0578
and/or advance directive.
Level of Harm - Minimal harm
or potential for actual harm
During a review of the facility provided P&P titled, “Resident Rights,” last reviewed 1/2025,
the P&P indicated federal and state laws guarantee certain basic rights to all residents of this facility. These
rights include the resident's right to choose a physician and treatment and participate in decisions and care
planning.
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 6 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's
ability to function.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure residents were free from unnecessary psychotropic
medication (medications that affect the mind, emotions, and behavior) and the use of chemical restraints
(any drug that is used for discipline or staff convenience and not required to treat medical symptoms) for
three of five sampled resident (Residents 219, 36, and 31) reviewed under the Unnecessary Medications,
Chemical Restraints / Psychotropic Medications care area by failing to: 1. Obtain informed consent
(voluntary agreement to accept treatment and/or procedures after receiving education regarding the risks,
benefits, and alternatives offered) prior to the administration of psychotropic medication for Resident 219. 2.
Provide ongoing re-evaluation of the need for psychotropic medication by failing to monitor for measurable
behaviors and adverse effects (unwanted, uncomfortable, or dangerous effects that a drug may have, such
as impairment or decline in an individual's mental or physical condition or functional or psychosocial status)
of bupropion (an antidepressant medication used to treat depression [persistent feelings of sadness and
loss of interest that can interfere with daily living]), diazepam (a medication used to relieve symptoms of
anxiety [a mental health condition that may result in restlessness, irritability, feelings of nervousness, panic,
and fear]), and duloxetine (a medication to treat depression and anxiety) for Resident 219. 3. Ensure as
needed (PRN) diazepam was prescribed for a specific, measurable behavioral manifestation for Resident
219. 4. Provide ongoing re-evaluation of the need for psychotropic medication by failing to ensure PRN
diazepam was ordered with an end date (time at which a medication will no longer be dispensed and will be
required to be re-prescribed) for Resident 219. 5. Monitor for measurable behaviors of Risperdal (an
antipsychotic medication-a drug used to manage abnormal condition of the mind described as involved a
loss of contact with reality) from 2/18/2025 to 2/28/2025 for Resident 36. 6. Provide ongoing re-evaluation
for the indications for use of Risperdal and Klonopin (a psychotropic medication used for anxiety [a feeling
of fear, dread, and uneasiness]) when the Behavior Summary Side Effects sheet (a document that outlines
information about psychotropic medications which includes focus on indications for use, side effects,
dosage, and frequency) was not completed for the months 2/2025, 3/2025, 5/2025, and 6/2025 for
Resident 36. 7. Monitor for measurable behaviors and adverse effects of Seroquel (an antipsychotic
medication used to treat mental health conditions such as schizophrenia [a mental illness that is
characterized by disturbances in thoughts]and bipolar disorder [mood swings that range from the lows of
depression to elevated periods of emotional highs]) for Resident 31. These deficient practices had the
potential to result in the administration of unnecessary psychotropic medication resulting in chemical
restraints and placed residents at risk for decline in physical functioning, isolation (a state of reduced social
interaction and lack of meaningful connections with others), and injury from falls. Findings:
1. During a review of Resident 219’s admission Record (AR), the AR indicated the facility admitted
the resident on 6/18/2025 with diagnoses that included hemiplegia (total paralysis of the arm, leg, and trunk
on the same side of the body) and hemiparesis (partial paralysis or weakness on one side of the body)
following cerebrovascular infarction (CVA-stroke, loss of blood flow to a part of the brain) affecting the right
dominant side, lack of coordination, history of falls, depression, and anxiety disorder.
During a review of Resident 219’s Minimum Data Set (MDS – resident assessment tool)
dated 6/23/2025, the MDS indicated the resident was able to understand others and was able to make
herself understood. The MDS further indicated that the resident was dependent on staff for toileting,
bathing, and lower body dressing; and required substantial / maximal assistance for upper body
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 7 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
dressing, personal hygiene, and transferring from the bed to chair. The MDS indicated that the resident was
administered the following high-risk medications (drugs that can cause significant patient harm if used
incorrectly): antianxiety and antidepressant.
During a review of Resident 219’s History and Physical (H&P), dated 6/19/2025, the H&P indicated
the resident had the capacity to understand and make decisions.
During a review of Resident 219’s Order Recap Summary, the Order Recap Summary indicated the
following physician’s orders:
-Bupropion HCl extended release (SR) oral tablet SR 12 hour 150 milligrams (mg, a unit of measurement),
give one tablet by mouth one time a day for depression manifested by (M/B) negative statements about
health. Informed consent obtained from medical doctor, dated 6/18/2025.
-Diazepam oral tablet five mg, give one tablet by mouth every 12 hours PRN for anxiety, dated 6/18/2025.
-Duloxetine HCl oral capsule delayed release particles 60 mg, give one capsule by mouth one time a day
for depression M/B reduced social interaction, dated 6/18/2025.
During an observation and interview on 6/30/2025 at 9:25 a.m., observed Resident 219 sitting in the
wheelchair in the hallway near the resident’s room. Resident 219 stated the facility nurse’s
do not tell Resident 219 what medications the resident is taking. Resident 219 stated the resident fell while
in the facility.
1.a. During a concurrent interview and record review on 7/1/2025 at 12:22 p.m. with Licensed Vocational
Nurse (LVN) 2, LVN 2 reviewed Resident 219’s physician orders and medication administration
record (MAR- a record of all medications taken by a resident on a day-to-day basis) for 6/2025. LVN 2
stated psychotropic medications are high-risk medications that can cause adverse effects in residents like
confusion, lethargy, and dizziness potentially resulting in resident falls with injury.
During a concurrent interview and record review on 7/3/2025 at 8:09 a.m. with the MDS Coordinator
(MDSC), the MDSC reviewed the facility P&P regarding psychotropic medication, Resident 219’s
physician orders, and MAR for 6/2025. The MDSC stated psychotropic medications affect the brain and
behavior of residents. The MDSC stated the facility process for the administration of psychotropic
medication was the following:
1.Clarify with the resident that the resident understands the medications prescribed and the physician will
obtain informed consent.
2.The consent form is then completed for each psychotropic medication.
3.The resident will be monitored every shift for potential side effects of the medication.
4.The resident will be monitored every shift for behavioral manifestations.
5.Monitoring is documented every shift in the MAR, and behaviors are tallied to ensure the medication is
effective.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 8 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
The MDSC further stated it was important for the physician to get informed consent from the resident
because psychotropic medications are considered high risk medications with potential for adverse effects
like tardive dyskinesia (a movement disorder that causes a range of repetitive muscle movements in the
face, neck, arms, and legs), sedation, and overall decline in the medical condition. The MDSC stated there
was no documented evidence that informed consent was obtained prior to the administration of Resident
219’s diazepam or duloxetine. The MDSC stated that when residents are administered psychotropic
medication without their consent, it could be considered a chemical restraint because the medication
modifies a resident’s behavior and may restrict their free will. The MDSC stated the admitting nurse
did not follow the facility P&P when informed consent was not obtained potentially resulting in the resident
taking medications, they were not aware of and that could potentially affect their medical and mental health.
During a concurrent interview and record review on 7/3/2025 at 9 a.m. with the Director of Nursing (DON),
the DON reviewed the facility P&P regarding psychotropic medication. The DON stated that informed
consent must be obtained for the administration of psychotropic medication because there are side effects
to the medications. The DON stated psychotropics change a resident’s behavior and it is important
to get the residents consent because residents have the right to refuse any treatment, including
medications that affect behavior. The DON stated the facility cannot administer medications if a resident
does not want the medication. The DON stated when informed consent was not obtained from Resident
219’s diazepam and duloxetine; the facility P&P was not followed and there was a potential for
Resident 219 to be considered chemically restrained and to have received unnecessary medications
potentially resulting in side effects causing injury.
During a review of the facility provided P&P titled, “Psychotropic Medication Use,” reviewed
1/2025, the P&P indicated residents will not receive medications that are not clinically indicated to treat a
specific condition. A psychotropic medication is any medication that affects the brain activity associated
with mental processes and behavior. Drugs in the following categories are considered psychotropic
medications and are subject to prescribing, monitoring, and review requirements specific to psychotropic
medications: anti-depressants and anti-anxiety medication. Residents have the right to decline treatment
with psychotropic medications.
During a review of the facility provided policy and procedure (P&P) titled, “Psychoactive Medication
Informed Consent,” reviewed 1/2025, the P&P indicated it is the policy of the facility to ensure that
an informed consent is obtained for each resident's psychoactive medication. The purpose of the policy is
to ensure that informed consent has been obtained and verified prior to initiation of psychotropic medication
use. Fundamental Information: resident has the right to be free from any physical or chemical restraints
imposed for purposes of discipline or convenience and not required to treat the resident's medical
symptoms.
Procedure:
1.Before prescribing a psychotherapeutic drug, the prescriber must personally examine the resident and
obtain informed written consent signed by the resident or the resident's representative along with, the
signature of the health care professional declaring that the required material information has been
provided.
2.If the resident or resident's representative cannot sign the form, a licensed nurse can sign the form and
document the name of the person who gave consent and the date.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 9 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Medical Records:
Level of Harm - Minimal harm
or potential for actual harm
a. The signed written consent must be recorded in the resident's medical record.
Residents Affected - Some
b. Before initiating treatment with psychotherapeutic drugs, facility staff shall verify that the resident's health
record contains written informed consent with the required signatures.
During a review of the facility provided P&P titled, “Resident Rights,” reviewed 1/2025, the
P&P indicated federal and state laws guarantee certain basic rights to all residents of this facility. These
rights include the resident's right to: Choose a physician and treatment and participate in decisions and
care planning.
1.b During a concurrent interview and record review on 7/1/2025 at 12:22 p.m. with LVN 2, LVN 2 reviewed
Resident 219’s physician orders and MAR for 6/2025. LVN 2 stated psychotropic medications are
high-risk medications that can cause adverse effects in residents like confusion, lethargy, and dizziness
potentially resulting in resident falls with injury. LVN 2 stated that because of the adverse effects, the goal
for psychotropic medication administration is to have a gradual dose reduction (GDR, tapering of a dose to
determine if symptoms, conditions, or risks can be managed by a lower dose or if the medication can be
discontinued) to avoid unnecessary medication in residents. LVN 2 stated psychotropic medication is
prescribed with specific, measurable behavioral manifestations to monitor to evaluate for an increase or
decrease in the resident’s behavior. LVN 2 stated if behaviors decrease then the facility can attempt
a GDR.
During a concurrent interview and record review on 7/2/2025 at 1:40 p.m. with Registered Nurse (RN) 1,
RN 1 reviewed the facility P&P regarding psychotropic medication, Resident 219’s physician orders,
and MAR for 6/2025. RN 1 stated psychotropic medication needs to be monitored for adverse effects and
the specific behaviors for the drug administration. RN 1 stated it was important to monitor to know if the
medication was working. RN 1 stated if a medication is no longer needed, then the goal is to do a GDR
because higher levels of psychotropic medication can cause harm to a resident. RN 1 reviewed Resident
219’s MAR and noted the following:
-Bupropion was not monitored for the specific behavior of negative statements about health.
-Duloxetine was not monitored for the specific behavior of reduced social interaction.
-And, bupropion, duloxetine, and diazepam were not monitored for potential side effects.
During a concurrent interview and record review on 7/3/2025 at 8:09 a.m. with the MDSC, the MDSC
reviewed the facility P&P regarding psychotropic medication, Resident 219’s physician orders, and
MAR for 6/2025. The MDSC stated psychotropic medications affect the brain and behavior of residents. The
MDSC stated the facility process for the administration of psychotropic medication was the following:
1.Clarify with the resident that the resident understands the medications prescribed and the physician will
obtain informed consent.
2.The consent form is then completed for each psychotropic medication.
3.The resident will be monitored every shift for potential side effects of the medication.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 10 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
4.The resident will be monitored every shift for behavioral manifestations.
Level of Harm - Minimal harm
or potential for actual harm
5.Monitoring is documented every shift in the MAR, and behaviors are tallied to ensure the medication is
effective.
Residents Affected - Some
The MDSC further stated the overall goal is that the residents will be able to do activities of daily living on
the minimum dosage of psychotropic medications to minimize the side effects. The MDSC stated that when
there is no monitoring of psychotropic medication then there is no way to know how the medication is
affecting the resident. The MDSC stated without monitoring there is a risk that a resident would be
overmedicated potentially resulting in harm from falls. The MDSC stated there was no documented
evidence that Resident 219 was monitored for behaviors or the potential side effects for the administration
of diazepam, duloxetine, or bupropion. The MDSC stated the facility P&P was not followed.
During a concurrent interview and record review on 7/3/2025 at 9 a.m. with the DON, the DON reviewed the
facility P&P regarding psychotropic medication. The DON stated psychotropics change a resident’s
behavior. The DON stated when there was no monitoring for Resident 219’s diazepam, duloxetine,
and bupropion; the facility P&P was not followed and there was a potential for Resident 219 to be
considered chemically restrained and to have received unnecessary medications potentially resulting in
side effects causing injury.
During a review of the facility provided P&P titled, “Psychotropic Medication Use,” reviewed
1/2025, the P&P indicated residents will not receive medications that are not clinically indicated to treat a
specific condition. Drugs in the following categories are considered psychotropic medications and are
subject to prescribing, monitoring, and review requirements specific to psychotropic medications:
anti-depressants and anti-anxiety medication. Psychotropic medication management includes adequate
monitoring for efficacy and adverse consequences; and preventing, identifying and responding to adverse
consequences. Residents on psychotropic medication receive GDR in an effort to discontinue the
medication. Residents receiving psychotropic medications are monitored for adverse consequences. When
determining whether to initiate, modify, or discontinue medication therapy, the IDT conducts an evaluation
of the resident.
During a review of the facility provided P&P titled, “Adverse Consequences and Medication
Errors,” reviewed 1/2025, the P&P indicated the interdisciplinary team monitors medication usage in
order to prevent and detect medication-related problems such as adverse drug reactions (ADRs) and side
effects. An adverse consequence refers to an unwanted, uncomfortable or dangerous effect that a drug
may have, such as a decline in mental or physical condition, or functional or psychosocial status. The staff
and practitioners strive to minimize adverse consequences by:
-Following relevant clinical guidelines and manufacturer's specifications for use, dose, administration,
duration, and monitoring of the medication.
Residents receiving medication are monitored for adverse consequences. Adverse consequences are
promptly identified and reported. When a resident receives a new medication order, review the following:
-The dose, route of administration, duration, and monitoring are in agreement with current clinical practice,
clinical guidelines, and/or manufacturer's specifications for use.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 11 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
1.c. During a concurrent interview and record review on 7/1/2025 at 12:22 p.m. with LVN 2, LVN 2 reviewed
Resident 219’s physician orders and MAR for 6/2025. LVN 2 stated psychotropic medications are
high-risk medications that can cause adverse effects in residents like confusion, lethargy, and dizziness
potentially resulting in resident falls with injury. LVN 2 stated that because of the adverse effects, the goal
for psychotropic medication administration is to have a GDR to avoid unnecessary medication in residents.
LVN 2 stated psychotropic medication is prescribed with specific, measurable behavioral manifestations to
monitor to evaluate for an increase or decrease in the resident’s behavior. LVN 2 stated if behaviors
decrease then the facility can attempt a GDR. LVN 2 stated Resident 219’s diazepam was ordered
for anxiety. LVN 2 stated anxiety is not a specific behavioral manifestation. LVN 2 stated the medication
nurses should have clarified with the physician and updated the order to include Resident 219’s
behavior of verbalizing that the resident felt anxious, but they did not.
During a concurrent interview and record review on 7/2/2025 at 1:40 p.m. with RN 1, RN 1 reviewed the
facility P&P regarding psychotropic medication, Resident 219’s physician orders, and MAR for
6/2025. RN 1 stated anxiety is a psychiatric diagnosis and not behavior. RN 1 stated residents display
behaviors of anxiety like shortness of breath or verbalizing fear. RN 1 stated if a specific behavior is not
included in the physician’s order, then the admitting nurse should clarify with the physician. RN 1
stated Resident 219’s order for PRN diazepam did not include a specific behavioral manifestation
for administration, but it should have. RN 1 stated when Resident 219’s PRN diazepam order did not
include a specific behavior, the facility P&P was not followed with a potential to result in the medication
causing harm in the resident.
During an interview on 7/2/2025 at 2:32 p.m. with the DON, the DON stated psychotropics have a high risk
for side effects like over sedation resulting in resident falls. The DON stated psychotropics should be
administered and monitored for specific behaviors to know if the residents have a continued need for the
medication. The DON stated the behavior monitoring data is used for a GDR with a goal of decreasing and
discontinuing medication. The DON stated Resident 219’s physician order for PRN diazepam
indicates to give the medication for anxiety. The DON stated anxiety is not a specific behavior.
During a follow-up concurrent interview and record review on 7/3/2025 at 9 a.m. with the DON, the DON
reviewed the facility P&P regarding psychotropic medication. The DON stated when Resident 219’s
diazepam was not ordered with a specific behavioral manifestation; the facility P&P was not followed and
there was a potential for Resident 219 to be considered chemically restrained and to have received
unnecessary medications potentially resulting in side effects causing injury.
During a review of the facility provided P&P titled, “Psychotropic Medication Use,” reviewed
1/2025, the P&P indicated residents will not receive medications that are not clinically indicated to treat a
specific condition. A psychotropic medication is any medication that affects the brain activity associated
with mental processes and behavior. Drugs in the following categories are considered psychotropic
medications and are subject to prescribing, monitoring, and review requirements specific to psychotropic
medications: anti-depressants and anti-anxiety medication. Psychotropic medication management includes
adequate monitoring for efficacy and adverse consequences. Residents on psychotropic medication
receive GDR in an effort to discontinue the medication. Psychotropic medications are not prescribed or
given on a PRN basis unless the medication is necessary to treat a specific diagnosed condition that is
documented in the clinical record. When determining whether to initiate, modify, or discontinue medication
therapy, the IDT conducts an evaluation of the resident.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 12 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
During a review of the facility provided P&P titled, “Adverse Consequences and Medication
Errors,” reviewed 1/2025, the P&P indicated the interdisciplinary team monitors medication usage in
order to prevent and detect medication-related problems such as adverse drug reactions (ADRs) and side
effects. The staff and practitioners strive to minimize adverse consequences by:
-Following relevant clinical guidelines and manufacturer's specifications for use, dose, administration,
duration, and monitoring of the medication.
-Defining appropriate indications for use.
1.d. During a concurrent interview and record review on 7/1/2025 at 12:22 p.m. with LVN 2, LVN 2 reviewed
Resident 219’s physician orders and MAR for 6/2025. LVN 2 stated psychotropic medications are
high-risk medications that can cause adverse effects in residents like confusion, lethargy, and dizziness
potentially resulting in resident falls with injury. LVN 2 stated that because of the adverse effects, the goal
for psychotropic medication administration is to have a GDR to avoid unnecessary medication in residents.
LVN 2 stated all PRN psychotropic medication should be prescribed with a stop date when the physician
will reassess the need for the high-risk medication. LVN 2 stated Resident 219’s PRN diazepam was
not prescribed with a stop date, but it should have been.
During a concurrent interview and record review on 7/2/2025 at 1:40 p.m. with RN 1, RN 1 reviewed the
facility P&P regarding psychotropic medication, Resident 219’s physician orders, and MAR for
6/2025. RN 1 stated PRN psychotropic medications are ordered with a 14 day stop date and then the
resident needs to be re-evaluated because the medication may no longer be needed. RN 1 stated if a
resident no longer needs psychotropic medication, the medication should no longer be administered due to
the increased risk for harm from side effects. RN 1 stated Resident 219’s PRN diazepam order did
not have a stop date, and the facility P&P was not followed with a potential to result in the medication
causing falls resulting in harm to the resident.
During a concurrent interview and record review on 7/3/2025 at 9 a.m. with the DON, the DON reviewed the
facility P&P regarding psychotropic medication. The DON stated when PRN diazepam was not ordered with
an end date for Resident 219’s diazepam, the facility P&P was not followed and there was a
potential for Resident 219 to have received unnecessary medications potentially resulting in side effects
causing injury.
During a review of the facility provided P&P titled, “Psychotropic Medication Use,” reviewed
1/2025, the P&P indicated residents will not receive medications that are not clinically indicated to treat a
specific condition. A psychotropic medication is any medication that affects the brain activity associated
with mental processes and behavior. Drugs in the following categories are considered psychotropic
medications and are subject to prescribing, monitoring, and review requirements specific to psychotropic
medications: anti-depressants and anti-anxiety medication. PRN orders for psychotropic medications that
are not antipsychotics: if the prescriber or attending physician believes it is appropriate to extend the PRN
order beyond 14 days, he or she will document the rationale for extending the use and include the duration
for the PRN order.
2. During a review of Resident 36’s AR, the AR indicated the facility originally admitted the resident
on 8/16/2024 and readmitted on [DATE] with diagnoses including dementia (a progressive state of decline
in mental abilities), anxiety disorder (an abnormal condition characterized by persistent and excessive
worries that interfere with daily activities), and respiratory failure (a serious condition that makes it difficult
to breathe on your own).
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 13 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
During a review of Resident 36’s H&P, dated 2/19/2025, the H&P indicated the resident has the
capacity to understand and make decisions.
During a review of Resident 36’s MDS, dated [DATE], the MDS indicated the resident had adequate
hearing and unclear speech, usually made self-understood, and had the ability to understand others. The
MDS indicated the helper does all the effort for the resident’s activities of daily living including oral
hygiene, toileting hygiene, shower/bathing self, upper and lower body dressing, putting on/taking off
footwear, and personal hygiene. The MDS indicated that the resident was taking high-risk drug classes
(medications at risk of side effects that can adversely affect health, safety, and quality of life) including
antipsychotic and antianxiety medications.
During a review of Resident 36’s Order Summary Report, the Order Summary Report indicated:
- Klonopin oral tablet, one (1) milligram (mg-a unit of measurement), give 1 tablet via gastrostomy (a
surgical opening fitted with a device to allow feedings to be administered directly to the stomach common
for people with swallowing problems) tube (g-tube) two times a day for anxiety with agitation manifested by
physical restlessness as evidenced by trashing back and forth in bed, dated 2/18/2025.
- Risperdal oral tablet, give 1.5 mg via g-tube two times a day for psychosis (a severe mental condition in
which thought, and emotions are so affected that contact is lost with reality) manifested by disrobing,
self-harm behaviors as evidenced by throwing self on floor, dated 2/18/2025.
- Monitor for anxiety with agitation manifested by physical restlessness as evidenced by trashing back and
forth in bed and tally by hashmark every shift for clonazepam (Klonopin), dated 2/18/2025.
- Monitor psychosis manifested by disrobing, self-harm behaviors as evidenced by trashing back and forth
in bed and tally by hashmark every shift, dated 3/1/2025.
During a concurrent interview and record review on 7/3/2025 at 9:37 a.m., with the MDSC, reviewed
Resident 36’s Behavior Summary Side Effects sheet and Medication Administration Record for the
month of 2/2025 to 6/2025. The MDSC stated the Behavior Summary Side Effects documented for the
month of 4/2025 only for Klonopin and Risperdal. The MDSC stated the MAR indicated the total behavior
exhibited by Resident 36:
Total behavior tally for Klonopin:
- 2/2025 - 0
- 3/2025 - 4
- 4/2025 - 0
- 5/2025 - 10
- 6/2025 - 42
Total behavior tally for Risperdal:
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 14 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
- 3/2025 - 0
Level of Harm - Minimal harm
or potential for actual harm
- 4/2025 - 0
- 5/2025 - 0
Residents Affected - Some
- 6/2025 – 0
During a concurrent interview and record review on 7/3/2025 at 10:10 a.m. with the MDSC, reviewed
Resident 36’s Order Summary Report, the MDSC stated there was no order for behavior monitoring
for the use of Risperdal from 2/18/2025 to 2/28/2025. The MDSC stated the behavior monitoring was
ordered on 3/1/2025. The MDSC stated once the licensed nurse receives the order for Risperdal it should
coincide with the monitoring for behavior and side effects. The MDSC stated the behavior is monitored to
evaluate if the medication is effective for Resident 36. The MDSC stated this could be a risk for
overmedicating Resident 36 and could have adverse effects such as drowsiness, confusion, and tardive
dyskinesia (a neurological movement disorder characterized by involuntary, repetitive, and sometimes
disfiguring muscle movements, particularly in the face, mouth, tongue, and limbs).
During an interview on 7/3/2025 at 12:25 p.m. with the DON, the DON stated the 11 p.m. to 7 a.m. shift
licensed nurse would be responsible in completing the behavior summary effect sheet. The DON stated this
document provides information if Resident 36’s behavior has increased or decreased, and they
could do a gradual dose reduction of the medication. The DON stated there should be a monitoring of the
resident’s behavior for the use of psychotropic medications because this is part of medication
management and gradual dose reduction.
During a review of the facility provided P&P titled, “Psychotropic Medication Use,” reviewed
1/2025, the P&P indicated residents will not receive medications that are not clinically indicated to treat a
specific condition. Drugs in the following categories are considered psychotropic medications and are
subject to prescribing, monitoring, and review requirements specific to psychotropic medications:
anti-depressants and anti-anxiety medication. Psychotropic medication management includes adequate
monitoring for e[TRUNCATED]
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 15 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Develop and implement a complete care plan that meets all the resident's needs, with timetables and
actions that can be measured.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to develop and implement a comprehensive care
plan (CP, a plan that includes measurable objectives and timetables to meet the resident's physical,
psychosocial and functional needs) by failing to: 1.Develop and implement a CP for an actual fall for one of
two sampled residents (Resident 219) reviewed during the Accidents care area. 2.Develop a CP to address
residents' bowel and bladder incontinence (having no or insufficient voluntary control over urination or
defecation) management and retraining one of two randomly sampled residents (Resident 119). These
deficient practices had the potential to result in miscommunication among interdisciplinary staff, residents,
and resident representatives resulting in a delay in care and services. Findings:
a. During a review of Resident 219’s admission Record (AR), the AR indicated the facility admitted
the resident on 6/18/2025 with diagnoses that included hemiplegia (total paralysis of the arm, leg, and trunk
on the same side of the body) and hemiparesis (partial paralysis or weakness on one side of the body)
following cerebrovascular infarction (CVA-stroke, loss of blood flow to a part of the brain) affecting the right
dominant side, lack of coordination, and history of falls, depression (persistent feelings of sadness and loss
of interest that can interfere with daily living), and anxiety disorder (a mental health condition that may
result in restlessness, irritability, feelings of nervousness, panic, and fear).
During a review of Resident 219’s Minimum Data Set (MDS – resident assessment tool)
dated 6/23/2025, the MDS indicated the resident was able to understand others and was able to make
herself understood. The MDS further indicated that the resident was dependent on staff for toileting,
bathing, and lower body dressing; and required substantial / maximal assistance for upper body dressing,
personal hygiene, and transferring from the bed to chair.
During a review of Resident 219’s History and Physical (H&P), dated 6/19/2025, the H&P indicated
the resident had the capacity to understand and make decisions.
During a review of Resident 219’s Care Plan (CP) titled, “The Resident is high risk for falls
related to unaware of safety needs,” initiated 6/18/2025, the CP indicated a goal that the resident
would be free from falls with interventions that included to follow facility fall protocol.
During an observation and interview on 6/30/2025 at 9:25 a.m. with Resident 219 and Licensed Vocational
Nurse (LVN) 3, observed Resident 219 sitting in a wheelchair in the hallway outside the resident’s
room. Resident 219 stated Resident 219 falls a lot and had fallen in the facility. LVN 3 stated Resident 219
last had a fall on 6/27/2025.
During a concurrent interview and record review on 7/1/2025 at 12:22 p.m., LVN 2 reviewed Resident
219’s Progress Notes for 6/2025, in progress (not completed) Post Fall Evaluation dated 6/27/2025,
Change of Condition (COC) form dated 6/27/2025, and care plans. LVN 2 stated when a resident has a fall
in the facility, the process is to complete a post fall evaluation right away to re-assess the resident’s
risk for falls and develop and implement a post fall CP with any new interventions. LVN 2 stated it is
important to implement a post fall CP to ensure the resident does not fall again. LVN 2 stated Resident 219
had a fall on 6/27/2025 and Resident 219 did not have a post fall CP, but there should have been one
created. LVN 2 stated Registered Nurse (RN) 1 completed the COC
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 16 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
form.
Level of Harm - Minimal harm
or potential for actual harm
During a concurrent interview and record review on 7/1/2025 at 1:47 p.m., RN 1 reviewed Resident
219’s Progress Notes for 6/2025, in progress Post Fall Evaluation dated 6/27/2025, COC form dated
6/27/2025, and care plans. RN 1 stated CPs are communication tools for all the staff to follow to provide
care for a resident. RN 1 stated every resident has an individualized CP according to their needs. RN 1
stated CPs are also important to re-evaluate the residents’ progress toward the CP goals. RN 1
stated Resident 219 had a fall on 6/27/2025. RN 1 stated Resident 219 should have a post fall CP from
6/27/2025 but did not. RN 1 stated the internet does not function well in the facility and RN 1 was not able
to create a CP in the computer. RN 1 stated without a post fall CP Resident 219 could have another fall
because new interventions may not be implemented.
Residents Affected - Few
During a concurrent interview and record review on 7/2/2025 at 2:32 p.m. with the Director of Nursing
(DON), the DON reviewed the facility Policy and Procedures (P&P) regarding CPs. The DON stated CPs
are resident centered plans of care. The DON stated a post fall CP should be completed right after a
resident has a fall to ensure the resident is monitored, new interventions are implemented, and future falls
are prevented. The DON stated that when Resident 219 had a fall and there was no post fall CP developed
and implemented, the resident could have sustained a fall with injury the very next day. The DON stated the
facility P&P was not followed.
During a review of the facility provided P&P titled, “Fall and Fall Risk, Managing,” last
reviewed 1/2025, the P&P indicated based on previous evaluations and current data, the staff will identify
interventions related to the resident's specific risks and causes to try to prevent the resident from falling and
to try to minimize complications from falling. If falling recurs despite initial interventions, staff will implement
additional or different interventions or indicate why the current approach remains relevant.
During a review of the facility provided P&P titled, “Care Plans, Comprehensive,” last
reviewed 1/2025, the P&P indicated an individualized comprehensive care plan that includes measurable
objectives and timetables to meet the resident's medical, nursing, mental and psychological needs is
developed for each resident. Each resident's comprehensive care plan is designed to:
a. Incorporate identified problem areas.
b. Incorporate risk factors associated with identified problems.
c. Build on the residents’ strengths.
d. Reflect the resident's expressed wishes regarding care and treatment goals.
e. Reflect treatment goals, timetables and objectives in measurable outcomes.
f. Identify the professional services that are responsible for each element of care.
g. Aid in preventing or reducing declines in the resident's functional status and/or functional levels.
h. Enhance the optimal functioning of the resident by focusing on a rehabilitative program; and
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 17 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
i. Reflect currently recognized standards of practice for problem areas and conditions.
Level of Harm - Minimal harm
or potential for actual harm
Care plan interventions are designed after careful consideration of the relationship between the
residents’ problem areas and their causes. When possible, interventions address the underlying
source(s) of the problem area(s), rather than addressing only symptoms or triggers. The resident's
comprehensive care plan is developed within seven (7) days of the completion of the resident's
comprehensive assessment (MDS). Assessments of residents are ongoing, and care plans are revised as
information about the residents and the resident's condition change.
Residents Affected - Few
b. During a review of Resident 119’s AR, the AR indicated the facility admitted the resident on
5/27/2025 with diagnoses including anxiety disorder, bipolar disorder (mood swings that range from the
lows of depression to elevated periods of emotional highs), neuropathy (disease or dysfunction of one or
more nerves, typically causing numbness or weakness in the hands and feet), and psychosis (a severe
mental condition in which thought, and emotions are so affected that contact is lost with reality).
During a review of Resident 119’s “H&P,” dated 5/27/2025, the “H&P”
indicated, Resident 1 had the capacity to understand and make decisions.
During a review of Resident 119’s MDS dated [DATE], the MDS indicated Resident 119’s
cognitive functioning (mental processes that enable people to think, understand, make decisions, and
complete tasks) was intact. The MDS further indicated that Resident 119 required moderate assistance with
upper body dressing, personal hygiene, bathing, and was dependent on lower body dressing, transferring
from the bed to chair and moving from lying to sitting position.
During an interview on 7/3/2025 at 12:12 p.m. with the MDS Coordinator (MDSC), MDSC stated bladder
and bowel management, and retraining care plan was not initiated for Resident 119. MDSC stated
residents’ care plan should be comprehensive and include all aspects of residents’ care.
MDSC stated the failure to initiate and implement a comprehensive care plan that would include bladder
and bowel retraining program for Resident 119 could potentially result in delay of care, negatively affecting
Resident 119’s well-being.
During an interview on 7/3/2025 at 12:26p.m. with the DON, the DON stated bowel and bladder
management, and retraining care plan should have been initiated for Resident 119. The DON stated
comprehensive care plan provides the guiding steps of resident care. The DON stated the failure to initiate
the care plan could potentially prevent Resident119 from receiving care leading to increased risk of
incontinence and negatively affect Resident 119’s psychosocial well-being.
During a review of the facility-provided P&P titled, “Care Plan-Comprehensive,” last reviewed
on 01/2025, the P&P indicated, “An individualized comprehensive care plan that includes
measurable objectives and timetables to meet the resident’s medical, nursing, mental and
psychological needs is developed for each resident. 1. Our facility’s Care Planning/Interdisciplinary
Team, in coordination with the resident, his/her family or representative (sponsor), develops and maintains
a comprehensive care plan for each resident that identifies the highest level of functioning the resident may
be expected to attain. 2. The comprehensive care plan is based on a thorough assessment that includes,
but is not limited to the MDS. 3. Each resident’s comprehensive care plan is designed to : a.
incorporate identified problem area; b. Incorporate risk factors associated with identified problems; c. Build
on the resident’s strengths;…h. Enhance the optimal functioning of the resident by focusing on
a rehabilitative program.”
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 18 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
Ensure services provided by the nursing facility meet professional standards of quality.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure services provided meet professional standards of
quality in accordance with professional standards and comprehensive care plan for two of two sampled
residents (Residents 25 and 31) by failing to ensure: 1. Subcutaneous (beneath the skin) insulin (a
hormone that lowers the level of glucose [a type of sugar] in the blood) administration sites were rotated (a
method to ensure repeated injections are not administered in the same area) for Resident 25. 2. Resident
31's Psychotropic medications (medications that affect the mind, emotions, and behavior) had documented
evidence for the diagnosis of schizophrenia (a mental illness that is characterized by disturbances in
thoughts). These deficient practices had the potential for Residents 25 and 31 to experience adverse effect
(unwanted, unintended result) and negatively affect the residents' well-being Cross Reference with F760
Findings: a. During a review of Resident 25's admission Record (AR), the AR indicated the facility admitted
Resident 25 on 8/31/2016 and readmitted on [DATE] with diagnoses including diabetes mellitus (DM-a
disorder characterized by difficulty in blood sugar control and poor wound healing), chronic obstructive
pulmonary disease (COPD-a chronic lung disease causing difficulty in breathing, and congestive heart
failure (CHF-a heart disorder which causes the heart to not pump the blood efficiently, sometimes resulting
in leg swelling). During a review of Resident 25's Care Plan (CP), initiated on 8/23/2024, the CP indicated
Resident 25 had diabetes mellitus. The CP interventions indicated to administer diabetes medications as
ordered by the doctor. During a review of Resident 25's History and Physical (H&P), dated 10/25/2024, the
H&P indicated, Resident 25 had the capacity to understand and make decisions. During a review of
Resident 25's Minimum Data Set (MDS-resident assessment tool) dated 5/9/2025, the MDS indicated
Resident 25's cognitive functioning (mental processes that enable people to think, understand, make
decisions, and complete tasks) was intact. The MDS also indicated Resident 25 required supervision with
showers, bed to chair transfers, and toilet transfers. During a review of Resident 25's Order Summary
Report, the Order Summary Report indicated the following physician's order: -2/9/2025: Insulin Glargine
(Lantus SoloStar- a long-acting insulin that provides a consistent level of insulin in the body over
approximately 24 hours) Subcutaneous Solution Pen-Injector (a medical device designed for easy and
accurate administration of injectable medication) 100 unit per milliliter (unit/ml - a unit of measurement).
Inject 90 units subcutaneously in the morning. Rotate Site. Hold if blood sugar (BS-body's main source of
energy) is less than 100. During a concurrent interview and record review on 7/2/2015 at 2:50 p.m. with
Licensed Vocational Nurse (LVN) 4, Resident 25's Medication Administration Record (MAR), dated 6/2025
was reviewed. The MAR indicated insulin glargine was administered as follows: 6/4/25 06:00 6/4/25 06:27
subcutaneously Abdomen-left upper quadrant (LUQ) 6/5/25 06:00 6/5/25 06:13 subcutaneously AbdomenLUQ 6/6/25 06:00 6/6/25 05:20 subcutaneously Arm-right 6/7/25 06:00 6/7/25 05:52 subcutaneously
Arm-right 6/15/25 06:00 6/15/25 05:18 subcutaneously Abdomen-left lower quadrant (LLQ) 6/16/25 06:00
6/16/25 06:13 subcutaneously Abdomen-LLQ 6/17/25 06:00 6/17/25 06:01 subcutaneously Abdomen-LLQ
6/20/25 06:00 6/20/25 06:33 subcutaneously Abdomen-LLQ 6/21/25 06:00 6/21/25 05:11 subcutaneously
Abdomen-LLQ LVN 4 stated the insulin administration sites should have been rotated during each
administration. LVN 4 stated the failure to rotate insulin administration sites had the potential for Resident
25 to experience skin problems, adverse effects and affect the absorption of the insulin. During an interview
on 7/2/2025 at 3:05 p.m. with Registered Nurse (RN) 1, RN 1 stated licensed staff should have rotated
insulin administration sites. RN 1 stated the failure to rotate insulin administration sites had the potential to
damage Resident 25's subcutaneous tissue. During an interview on 7/3/2025 at 12:26 p.m.
Residents Affected - Few
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 19 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0658
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
with the Director of Nursing (DON), the DON stated insulin administration sites should be rotated. The DON
stated the failure to rotate insulin administration sites had the potential to cause cellulitis (a skin infection
that causes swelling and redness), damage the subcutaneous tissue and affect the absorption of the
medication. During a review of the facility provided manufacturer's guideline for Lantus dated 8/2022, the
guideline indicated to rotate injection sites to reduce the risk of lipodystrophy and localized cutaneous
amyloidosis at the injection site. During a review of the facility-provided policy and procedure (P&P) titled,
Insulin Administration, last reviewed on 1/2025, the P&P indicated, Injection sites should be rotated,
preferably in the same general area (abdomen, thigh, upper arm). b. During a review of Resident 31's
admission Record (AR), the AR indicated the facility admitted Resident 31 on 4/25/2025 and readmitted on
[DATE] with diagnoses including anxiety disorder (feeling of anxiousness that affects daily life), bipolar
disorder, and end stage renal disease (ESRD-irreversible kidney failure). During a review of Resident 31's
MDS, dated [DATE], the MDS indicated Resident 31's cognitive functioning was moderately impaired. The
MDS also indicated Resident 31 required moderate assistance with oral hygiene, personal hygiene, and
maximal assistance with toileting hygiene, showers, and chair to bed transfers. During a review of Resident
31's CP, initiated on 5/15/2025, the CP indicated Resident 31 had behavioral patterns of Schizophrenia
manifested by rapid mood cycling as evidenced by sudden shifts in mood from pleasant to extreme anger.
The CP also indicated residents were at risk for adverse effects from psychotropic medications. During a
review of Resident 31's Order Summary Report, the Order Summary Report indicated the following
physician's order: -5/26/2025: Seroquel (Quetiapine Fumarate) Oral Tablet 25 milligram (mg-unit of
measurement). Give 12.5mg by mouth two times a day for schizophrenia manifested by rapid mood cycling
as evidenced by sudden shifts in mood from pleasant to extreme anger, yelling and screaming. During a
concurrent interview and record review on 7/1/2025 at 2:32 p.m. with RN 1, Resident 31's General Acute
Care Hospital (GACH) records, dated 5/2025 were reviewed. The GACH records indicated Resident 31's
home medications included Seroquel. RN 1 stated Resident 31's facility records do not have documented
record of Schizophrenia diagnosis. During an interview on 7/3/2025 at 12:26 p.m. with the DON, the DON
stated there should have been documentation from the physician regarding Resident 31's diagnoses of
schizophrenia and evaluation for the indication of the psychotropic medication. The DON stated this failure
had the potential for Resident 31 to receive unnecessary medication and experience sedation, increasing
risk of injury. During a review of the facility-provided P&P titled, Psychotropic Medication Use, last reviewed
on 1/2025, the P&P indicated, Residents will not receive medications that are not clinically indicated to treat
a specific condition. 1. A psychotropic medication is any medication that affects brain activity associated
with mental processes and behavior. 2. Drugs in the following categories are considered psychotropic
medications and are subject to prescribing, monitoring, and review requirements specific to psychotropic
medications: a. Anti-psychotics. Residents who have not used psychotropic medications are not prescribed
or given these medications unless the medication is determined to be necessary to treat a specific
condition that is diagnosed and documented in the medical record. During a review of the facility-provided
P&P titled, Psychotropic Medication Use, last reviewed on 1/2025, the P&P indicated, An ‘adverse
consequence' refers to an unwanted, uncomfortable or dangerous effect that a drug may have, such as a
decline in mental or physical condition, or functional or psychosocial status. The staff and practitioner strive
to minimize adverse consequences by: a. Following relevant clinical guidelines and manufacturer's
specifications for use, dose, administration, duration, and monitoring of the medication.
Event ID:
Facility ID:
555132
If continuation sheet
Page 20 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0678
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Provide basic life support, including CPR, prior to the arrival of emergency medical personnel , subject to
physician orders and the resident’s advance directives.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to implement their policy and procedure on cardiopulmonary
resuscitation (CPR-an emergency procedure used to restart a person's heartbeat and breathing after one
or both have stopped) by failing to ensure one of three Certified Nursing Assistants (CNA) (CNA 4)
obtained her CPR certification credentialed by the American Red Cross (ARC-an organization providing
disaster relief, blood donation services, and health education) or the American Heart Association (AHA-an
organization focused on heart disease prevention, research, and education). This deficient practice had the
potential to result in a delay for the provision of CPR to residents in emergency situations. Findings: During
a review of CNA 4's CPR certificate, the CPR certification indicated a completion date of [DATE]. During a
concurrent interview and record review on [DATE] at 9:03 a.m. with the Director of Nursing (DON), reviewed
CNA 4's CPR certificate and the facility's policy and procedure (P&P) titled, Emergency Procedure Cardiopulmonary Resuscitation, the DON stated CNA 4 and CNAs are part of their CPR team. The DON
stated the P&P is to make sure all their staff are trained by the ARC or the AHA. The DON stated the
residents could potentially have an injury while their staff provides CPR/Basic Life Support (BLS -a
lifesaving technique used to save a victim in case of an emergency) to the residents. During a concurrent
interview and record review on [DATE] at 1:37 p.m. with the Director of Staff Development (DSD), reviewed
CNA 4's CPR certificate, the DSD stated CNA 4's CPR training was not accredited by the ARC or the AHA.
The DSD stated she will remove CNA 4 from the schedule and have her retrained for CPR. The DSD stated
she missed it when she did the hiring process for CNA 4. The DSD stated it is important that CNA 4's CPR
certificate is credentialed by the AHA or ARC to meet legal requirements and follow their policy. During a
review of the facility's P&P titled, Emergency Procedure - Cardiopulmonary Resuscitation, last reviewed
1/2025, the P&P indicated the personnel had completed training on the initiation of CPR and basic life
support, including defibrillation, for victims of sudden cardiac arrest. The P&P indicated for the preparation
for CPR that key clinical staff members who will direct resuscitative efforts, including non-licensed
personnel, are to obtain and/or maintain American Red Cross or American Heart Association certification in
BLS/CPR. The PNP indicated the CPR team in this facility shall include at least one nurse, one licensed
practical nurse/licensed vocational nurse, and two CNAs, all of whom have received training and
certification in CPR/BLS.
Event ID:
Facility ID:
555132
If continuation sheet
Page 21 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure residents received treatment and care in
accordance with professional standards of practice to meet the resident's physical, mental, and
psychosocial (relating to the interrelation of social factors and individual thoughts and behavior) needs for
one of one sampled resident (Resident 31) by failing to obtain physician orders for hemoglobin (a protein in
red blood cells that carry oxygen) monitoring before the administration of Epogen (a medication used to
treat anemia [a condition where the body does not have enough healthy red blood cells] by creating more
blood cells). This deficient practice had the potential for Resident 31 to experience adverse (unwanted,
unintended result) cardiovascular (heart and blood vessels) reactions and stroke (loss of blood flow to a
part of the brain). Findings: During a review of Resident 31's admission Record (AR), the AR indicated the
facility admitted Resident 31 on 4/25/2025 and readmitted on [DATE] with diagnoses including end stage
renal disease (ESRD-irreversible kidney failure), chronic obstructive pulmonary disease (COPD-a chronic
lung disease causing difficulty in breathing), and anemia. During a review of Resident 31's Minimum Data
Set (MDS-resident assessment tool), dated 4/30/2025, the MDS indicated Resident 31's cognitive
functioning (mental processes that enable people to think, understand, make decisions, and complete
tasks) was moderately impaired. The MDS also indicated Resident 31 required moderate assistance with
oral hygiene, personal hygiene, and maximal assistance with toileting hygiene, showers, and chair to bed
transfers. During a review of Resident 31's Order Summary Report, the Order Summary Report indicated
the following physician's order: -5/27/2025: Epogen (Epoetin Alfa) Injection Solution 10000 unit/milliliter
(unit/ml-unit of measurement). Inject 1 dose subcutaneously (beneath the skin) one time a day every
Tuesday for anemia. Hold if hemoglobin is greater (>) than 11. During a concurrent interview and record
review on 7/2/2015 at 3:05 p.m. with Registered Nurse (RN) 1, Resident 31's Medication Administration
Record (MAR), dated 6/2025 and Order Summary Report were reviewed. The MAR indicated, on 6/3/2025
for the 9 a.m. administration time and 6/10/2025 for the 9 a.m. administration time, there was a licensed
staff initials in the box for Resident 31's Epogen Injection Solution, indicating the medication was
administered. The Order Summary Report indicated there was no physician order to monitor Resident 31's
hemoglobin levels. RN 1 stated there was no physician order for the monitoring of the hemoglobin level for
Resident 31. RN 1 stated Epogen should not have been administered without monitoring of the hemoglobin
levels. RN 1 stated a physician order should have been obtained for weekly hemoglobin monitoring. RN 1
stated the failure to obtain and order for hemoglobin monitoring could potentially cause Resident 31 to
experience liver problems. During an interview on 7/2/2025 at 3:35 p.m. with the Director of Nursing (DON),
the DON stated it was the responsibility of the licensed staff to obtain order for hemoglobin monitoring for
Resident 31. The DON stated the failure to obtain a physician order and monitor hemoglobin levels prior to
administering Epogen had the potential to cause polycythemia (high hemoglobin concentration in the
blood) in Resident 31 negatively affecting her well-being. During a review of the facility provided
manufacturer's guideline for Epogen dated 9/2017, the guideline indicated to monitor hemoglobin levels at
least weekly until stable, then monitor at least monthly for CKD patients. The manufacturer's guideline also
indicated there is a greater risk for adverse cardiovascular reactions, and stroke when Epogen is
administered to target a hemoglobin level of greater than 11grams/deciliter (g/dL-unit of volume
measurement). During a review of the facility-provided policy and procedure (P&P) titled, Medication and
Treatment Orders, last reviewed on 01/2025, the P&P indicated, Orders for medications and treatments will
be consistent with principles of safe and effective order writing.Orders for
Residents Affected - Few
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 22 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
medications must include: . any interim follow-up requirements (pending culture and sensitivity reports,
repeat labs, therapeutic medication monitoring, etc.).
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 23 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0690
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Provide appropriate care for residents who are continent or incontinent of bowel/bladder, appropriate
catheter care, and appropriate care to prevent urinary tract infections.
Based on interview and record review, the facility failed to ensure residents who were incontinent (having
no or insufficient voluntary control) of bowel and bladder received services and assistance for one of one
sampled resident (Resident 119) by failing to implement the bowel and bladder retraining program when
Resident 119 was identified as a candidate for retraining. This deficient practice had the potential to result
in increased risk for urinary or bowel incontinence and negatively affecting Resident 119's psychosocial
well-being (refers to a resident's overall mental, emotional, and social health, encompassing aspects like
happiness, life satisfaction, self-esteem, social functioning, and a sense of purpose). Findings: During a
review of Resident 119's admission Record (AR), the AR indicated the facility admitted Resident 119 on
5/27/2025 with diagnoses including anxiety disorder (feeling of anxiousness that affects daily life), bipolar
disorder (mood swings that range from the lows of depression to elevated periods of emotional highs),
neuropathy (disease or dysfunction of one or more nerves, typically causing numbness or weakness in the
hands and feet), and psychosis (a severe mental condition in which thought, and emotions are so affected
that contact is lost with reality). During a review of Resident 119's History and Physical (H&P), dated
5/27/2025, the H&P indicated Resident 119 had the capacity to understand and make decisions. During a
review of Resident 119's Minimum Data Set (MDS-resident assessment tool) dated 6/3/2025, the MDS
indicated Resident 119's cognitive functioning (mental processes that enable people to think, understand,
make decisions, and complete tasks) was intact. The MDS further indicated that Resident 119 was always
incontinent of bladder and bowel, and was dependent on lower body dressing, transferring from the bed to
chair and moving from lying to sitting position. During a concurrent interview and record review on 7/3/2025
at 12:12 p.m. with MDS Coordinator (MDSC), Resident 119's Bowel and Bladder Program Screener, dated
5/27/25 was reviewed. The Bowel and Bladder Program Screener indicated Resident 119 was a candidate
for retraining. MDSC stated the purpose of the retraining program was to encourage and help residents to
regain control over bladder and bowel elimination. MDSC stated bowel and bladder retraining program
should have been initiated for Resident 119. MDSC stated this failure had the potential for Resident 119 to
experience physical decline, develop skin problems, and negatively affect Resident 119's psychosocial
well-being. During an interview on 7/3/2025 at 12:26 p.m. with the Director of Nursing (DON), the DON
stated facility failed to place Resident 119 on bowel and bladder retraining program. The DON stated this
failure had the potential to increase Resident 119's risk of incontinence, cause skin damage and negatively
affect Resident 119's well-being. During a review of the facility-provided policy and procedure (P&P) titled,
Urinary Continence and Incontinence, last reviewed on 01/2025, the P&P indicated, 1. The staff and
practitioner will appropriately screen for, and manage, individuals with urinary incontinence. 2. Management
of incontinence will follow relevant clinical guidelines. 3. The physician and staff will provide appropriate
services and treatment to help residents restore or improve bladder function and prevent urinary tract
infections to the extent possible.19. The staff will document the results of the toileting trail in the resident's
medical record. a. If the resident responds well, the toileting program will be continued.
Event ID:
Facility ID:
555132
If continuation sheet
Page 24 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0693
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure that feeding tubes are not used unless there is a medical reason and the resident agrees; and
provide appropriate care for a resident with a feeding tube.
Based on observation, interview, and record review, the facility failed to ensure residents receiving enteral
feeding (EF - also known as tube feeding, a method of supplying nutrients directly into the stomach)
received appropriate care and services to prevent complications by failing to ensure Licensed Vocational
Nurse (LVN) 5 did not use a syringe (a small hallow tube without a needle, fitted with a sliding plunger) to
push (the act of depressing the plunger in a syringe to apply force in order to advance medications through
the gastrostomy tube [GT or g-tube, a tube that is inserted into the stomach) medications through the GT
for one (1) of 1 sampled resident (Resident 36) reviewed during the Tube Feeding care area. This deficient
practice placed Resident 36 at increased risk for abdominal distention (when air or fluid accumulate in the
stomach causing expansion), nausea (an urge to vomit), and vomiting. Findings: During a review of
Resident 36's admission Record (AR), the AR indicated the facility originally admitted the resident on
8/16/2024 and most recently admitted the resident on 11/8/2024 with diagnoses that included metabolic
encephalopathy (a general term that describes brain disease, damage, or malfunction usually related to
inflammation within the body), dysphagia (difficulty swallowing), hypertensive heart disease with heart
failure (refers to heart problems that occur because of high blood pressure that is present over a long time),
anxiety disorder (a mental health condition that may result in restlessness, irritability, feelings of
nervousness, panic, and fear), depression (persistent feelings of sadness and loss of interest that can
interfere with daily living), presence of cardiac pacemaker (a small battery-operated device that helps the
heart beat in a regular rhythm), and presence of GT. During a review of Resident 36's Minimum Data Set
(MDS - resident assessment tool), dated 5/7/2025, the MDS indicated the resident usually was able to
understand others and usually was able to make themself understood. The MDS further indicated the
resident was dependent on staff for dressing, personal and oral hygiene, toileting, bathing, and mobility.
During a review of Resident 36's Order Summary Report, the Order Summary Report indicated the
following physician orders: 1.Arginine (a supplement that helps the body produce proteins) Oral Packet,
give 1 packet via G-Tube two times a day for supplement, dated 2/18/2025. 2.Buspirone (an anti-anxiety
medication) HCl Oral Tablet 5 mg, give 1 tablet via G-Tube two times a day for anxiety manifested by (m/b)
physical restlessness as evidenced by (AEB) thrashing back and forth in bed, dated 5/26/2025. 3.Apixaban
(medication used to treat and prevent blood clots [gel-like clumps of blood]) Oral Tablet five (5) mg, give 1
tablet via G-Tube two times a day for deep vein thrombosis (a serious condition where a blood clot forms in
a deep vein), monitor for bleeding, dated 02/18/2025. 4.Clonazepam (medication to prevent and treat
anxiety disorders) Oral Tablet 1 mg, give 1 tablet via G-Tube two times a day for anxiety with agitation m/b
physical restlessness AEB trashing back and forth in bed, dated 02/18/2025. 5.Risperidone (medication
used to treat mental disorders) Oral Tablet, give 1.5 mg via G-Tube two times a day for psychosis m/b
disrobing, self-harm behaviors AEB throwing self on floor. 6.Sennoside (medication used to treat
constipation) Oral Tablet 8.6 mg, give two tablets via G-Tube two times a day for severe constipation if no
bowel movement for 4 days. Hold for loose stools, dated 02/18/2025. During a Medication Administration
Observation on 7/2/2025 at 8 a.m., with LVN 5, observed LVN 5 prepare Resident 36's medications at
Station 1 Medication Cart. Observed LVN 5 prepare cups for water flush, and the following supplement and
medications to administer via GT: 1.Arginine one oral powder packet 2.Buspirone, one 5 mg tablet
3.Apixaban, one 5 mg tablet 4.Clonazepam, one 1 mg tablet 5.Risperidone one 1.5 mg tablet 6.Sennoside,
two 8.6 mg tablets Observed LVN 5 entered Resident 36's room with the medications and water flush in
cups, placed the medications and water on the resident's nightstand, and
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 25 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0693
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
assessed the resident's GT. LVN 5 was then observed to suction (draw the medication into the syringe
tube) the supplement and five medications into a syringe, place the syringe tip onto the GT and apply
pressure to the plunger to advance the medications by push method. LVN 5 was observed suctioning 30
milliliters (mL, a unit of measurement) of water into the syringe and then push the 30 mL of water into the
GT before and after each medication administration. LVN 5 exited Resident 36's room and stated LVN 5
used the push method to administer the GT medication and water. LVN 5 stated it was okay to slowly push
medication. LVN 5 stated using the gravity method (the act of removing the plunger, pouring medication into
the syringe, and allowing the medication to flow without applying force) is the preferred method to
administer medications by GT because it is more natural and ensures force is not applied to the GT. LVN 5
stated LVN 5 did not attempt to use the gravity method before using the push method to administer
Resident 36's medication because the resident's GT has been clogged in the past and LVN 5 assumed the
GT may be clogged. LVN 5 stated Resident 36's GT was not clogged. LVN 5 stated LVN 5 should have
attempted to use the gravity method, but LVN 5 forgot to. During a concurrent interview and record review
on 7/2/2025 at 2:32 with LVN 2 and the Director of Nursing (DON), the policy and procedures (P&P)
regarding GT medication administration were reviewed. The DON stated the facility policy is to administer
GT medication by gravity. The DON stated the plunger should be remove and medication should be poured
into the syringe. LVN 2 stated if a nurse needs to use the slow push method, there must be a physician's
order. LVN 2 stated even if there is a physician's order to use the slow push method, the nurse should
attempt to use the gravity method first. LVN 2 stated it was important to use the gravity method because
gravity simulates the natural process of digestion. LVN 2 stated the gravity method is preferable as to not
upset the resident's stomach. LVN 2 stated LVN 5 did not follow the facility P&P to use the gravity method of
GT medication administration. A review of the facility P&P titled, Administering Medications through an
Enteral Tube last reviewed 1/2024, The P&P indicated to attach the syringe to the GT without the plunger to
the end of the GT tubing and administer medication by gravity. Pour diluted medication into the barrel of the
syringe while holding the tubing slightly above the level of insertion, open the clamp and deliver medication
slowly.
Event ID:
Facility ID:
555132
If continuation sheet
Page 26 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695
Provide safe and appropriate respiratory care for a resident when needed.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to provide respiratory care consistent with
professional standards of practice for one of one resident (Resident 53) reviewed during Respiratory Care
by failing to ensure Resident 53's nasal cannula (a medical device that provides supplemental oxygen
therapy) was connected to the oxygen concentrator (a medical device that provides a concentrated source
of oxygen). This failure had the potential for Resident 53 to experience shortness of breath, respiratory
distress, and negatively affect Resident 53's well-being. Findings: During a review of Resident 53's
admission Record (AR), the AR indicated facility admitted Resident 53 on 10/18/2024 and readmitted on
[DATE] with diagnoses including respiratory failure with hypoxia (a condition when lungs cannot adequately
oxygenate the blood leading to hypoxemia [low blood oxygen levels]), congestive heart failure (CHF-a heart
disorder which causes the heart to not pump the blood efficiently, sometimes resulting in leg swelling), and
dementia (a progressive state of decline in mental abilities). During a review of Resident 53's Care Plan
(CP) titled, Risk for ineffective breathing pattern, initiated on 10/23/2024, the CP interventions indicated to
administer oxygen as prescribed. During a review of Resident 53's CP titled, Resident has an impaired gas
exchange related to dyspnea and shortness of breath, initiated on 1/15/2025, the CP interventions
indicated to administer oxygen and titrate oxygen to keep oxygen saturation greater than (>) 92 percent
(%-unit of measurement). During a review of Resident 53's History and Physical (H&P), dated 3/4/2025, the
H&P indicated Resident 53 did not have the capacity to understand and make decisions. During a review of
Resident 53's Minimum Data Set (MDS-resident assessment tool), dated 6/27/2025, the MDS indicated
Resident 53 had severely impaired cognitive functioning (mental processes that enable people to think,
understand, make decisions, and complete tasks). The MDS also indicated Resident 53 was dependent on
staff for eating, oral hygiene, toileting hygiene, showers, upper and lower body dressing. During a review of
Resident 53's Order Summary Report, the Order Summary Report indicated the following physician's
order: -3/20/2025: Oxygen: Oxygen at 2 liters (L-unit of volume measurement) per minute continuously, for
shortness of breath may titrate up to 5L if necessary 1L at a time. During a concurrent observation and
interview on 6/30/2025 at 1:57 p.m. with Licensed Vocational Nurse (LVN) 1 in Resident 53's room,
Resident 53 was observed in bed with nasal cannula placed near Resident's nostrils. Nasal cannula tubing
was observed disconnected from the concentrator, hanging from Resident 53's bed. LVN 1 stated the
oxygen tubbing should always be connected to the oxygen source and it is facility staff's responsibility,
including licensed staff and certified nurse assistants, to make sure the connection is intact. LVN 1 stated
failure to connect Resident 53's nasal cannula to the oxygen concentrator had the potential for Resident 53
to experience shortness of breath and oxygen desaturation (decrease in the oxygen saturation of the
blood). During an interview on 7/3/2025 at 12:35p.m with the Director of Nursing (DON), the DON stated
staff should routinely monitor oxygen tubing and make sure tubbing is intact and connected to the
concentrator. DON stated failure to connect the nasal canula to the oxygen concentrator had the potential
for Resident 53 to experience shortness of breath and respiratory distress. During a concurrent interview
and record review on 7/3/2025 at 1:05 p.m. with the MDS Coordinator (MDSC), the facility-provided policy
and procedure (P&P) titled, Oxygen Administration, last reviewed on 01/2025, was reviewed. The P&P
indicated, Check the tubing connected to the oxygen cylinder to assure that it is free of kinks.Adjust the
oxygen delivery device so that it is comfortable for the resident and the proper flow of oxygen is being
administered. Check the mask, tank, humidifying jar, etc. , to be sure they are in good working order and
are securely fastened. MDSC stated Oxygen Administration policy is
Residents Affected - Few
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 27 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695
the only facility policy addressing the monitoring of the oxygen administration.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 28 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0698
Provide safe, appropriate dialysis care/services for a resident who requires such services.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview and record review, the facility failed to ensure residents who received hemodialysis (HD,
process of removing waste products and excess fluid from the body) received treatment consistent with
professional standards of practice for one of one sampled residents (Resident 51) reviewed under the
Dialysis care area by failing to ensure adequate communication with the HD Center regarding no
documented assessments done before and after Resident 51's hemodialysis sessions. This deficient
practice placed Resident 51 at risk for a delay in care and services and a delay in detecting complications
resulting from HD. Findings: During a review of Resident 51's admission Record, the admission Record
indicated the facility admitted the resident on 2/21/2024 with diagnoses that included end stage renal
disease (the kidneys cease functioning on a permanent basis), dependence on renal dialysis, and diabetes
mellitus (DM-a disorder characterized by difficulty in blood sugar control and poor wound healing). During a
review of Resident 51's Minimum Data Set (MDS - resident assessment tool), dated 5/8/2025, the MDS
indicated the resident was able to understand others and was able to make themself understood. The MDS
further indicated the resident required supervision with eating, oral and personal hygiene, bathing,
dressing, and toileting. During a review of Resident 51's Order Summary Report, the Order Summary
Report indicated an order for HD at Hemodialysis Center (HD Center) 1, on Tuesday/Thursday/Saturday at
7:30 a.m., dated 1/1/2025. During a review of Resident 51's Care Plan (CP) regarding hemodialysis,
initiated 10/29/2024, the CP indicated a goal that the resident will have immediate interventions should any
signs or symptoms of complications from HD occur. During a concurrent interview and record review on
7/1/2025 at 1:14 p.m., Licensed Vocational Nurse (LVN) 2 reviewed Resident 51's Dialysis Assessment
forms for 6/2025, Progress Notes for 6/2025, and Vital Signs (measurements of the body's most basic
functions including blood pressure, heart rate, respiratory rate, and temperature) forms for 6/2025. LVN 2
stated the facility process for HD residents is an assessment is completed by the licensed nurse (LN) prior
to sending the residents to HD to ensure the resident is stable. LVN 2 stated when residents return from
HD, the licensed nurse immediately completes a post HD assessment because the residents are at risk for
being lethargic, bleeding, or a change in the vital signs. LVN 2 stated it is important to catch any change of
condition quickly to treat and minimize the effects of high blood pressure or bleeding. MDSN 1 stated the
Dialysis Assessment form documents that the licensed nurse completed pre and post HD assessments of
the resident. LVN 2 stated the HD center also completes the Dialysis Assessment form to communicate the
resident's weight before and after HD, lab values, and any medications administered at the center. LVN 2
stated the LN is responsible to contact the HD center if the form is not completed. LVN 2 stated Resident 51
has HD three times a week. LVN 2 reviewed Resident 51's Dialysis Assessment forms, Progress Notes,
and vital signs and noted the following: On 6/10/2025 there was no documented evidence of a post HD
assessment being completed. There was no documented communication from HD Center 1. On 6/17/2025
there was no documented evidence of a post HD assessment being completed. On 6/19/2025 there was no
documented evidence of a pre or post HD assessment being completed. On 6/21/2025 there was no
documented evidence of a post HD assessment being completed. On 6/24/2025 there was no documented
evidence of a post HD assessment being completed. On 6/26/2025 there was no documented evidence of
a post HD assessment being completed. LVN 2 stated when pre and post HD assessments were not
completed for Resident 51, and the HD Center was not followed up with by the LNs, there was a potential
for harm because the resident may have undetected bleeding or high blood pressure that resulting in
hospitalization. During a concurrent interview and record review on 7/1/2025 at 2:23 p.m. with Registered
Nurse (RN) 1, RN 1 reviewed the facility policy and procedures (P&P) regarding HD. RN 1 stated the facility
Residents Affected - Some
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 29 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0698
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
process is to monitor residents right when the resident returns from HD because there may be bleeding
from the HD access site (a way to reach the blood for dialysis) or the resident may have lost too much fluid
resulting in abnormal blood pressure. RN 1 stated it is a big risk to not assess and monitor residents before
and after HD. RN 1 stated when the Dialysis form was not completed, the LN's did not follow the facility
P&P to monitor HD residents. During a concurrent interview and record review on 7/2/2025 at 11:45 a.m.
with LVN 3, LVN 3 reviewed the Dialysis Assessment form dated 6/24/2025 and stated LVN 3 cared for
Resident 51 on 6/24/2025 and forgot to document monitoring post HD. During a concurrent interview and
record review on 7/2/2025 at 12 p.m. with LVN 5, LVN 5 reviewed the Dialysis Assessment form dated
6/26/2025 and stated LVN 5 cared for Resident 51 on 6/26/2025 and forgot to document monitoring before
HD. LVN 5 stated in nursing if it was not documented then it was not done. During a review of the facility
provided P&P titled, End-Stage Renal Disease, Care of Resident with, last reviewed 1/2024, the P&P
indicated residents with end-stage renal disease (ESRD) will be cared for according to currently recognized
standards of care. Staff caring for residents with ESRD, including residents receiving dialysis care outside
the facility, shall be trained in the care and special needs of these residents. Education and training of staff
includes: the type of assessment data that is to be gathered about the resident's condition on a daily or per
shift basis. Signs and symptoms of worsening condition and/or complications of ESRD. How to intervene
and recognize medical emergencies. During a review of the facility provided P&P titled, Hemodialysis
Catheters - Access and Care of, last reviewed 1/2024, the P&P indicated care immediately following HD
includes to apply pressure if there is bleeding at the HD site and contact emergency services and HD
center. This is a medical emergency. Do not leave the residents alone until emergency services arrive. The
nurse should document in the resident's medical record observations post-dialysis.
Event ID:
Facility ID:
555132
If continuation sheet
Page 30 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0730
Observe each nurse aide's job performance and give regular training.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview and record review, the facility failed to complete a performance review for two of two
Certified Nursing Assistants or CNAs (CNA 2 and CNA 3) once every 12 months. This deficient practice
had the potential to result in placing residents at risk or reducing care quality. Findings: During a concurrent
interview and record review on 7/2/2025 at 8:45 a.m. with the Director of Staff Development (DSD), the
DSD stated licensed nurses and CNAs complete an annual competency and performance evaluation based
on hire date. During a concurrent interview and record review on 7/2/2025 at 9:11 a.m. with the DSD,
reviewed CNA 2's employee file, the DSD stated CNA 2's hire date was 6/29/2018 and her last competency
skills check was done on 6/21/2023. The DSD stated the competency skills check for the year 2024 was not
done for CNA 2. The DSD stated it should have been done on 6/2024 by the previous DSD. The DSD stated
competency is done annually to make sure their nurses are competent with their skills and ensure the right
care is provided to their residents. During a concurrent interview and record review on 7/2/2025 at 9:17
a.m. with the DSD, reviewed CNA 3's employee file, the DSD stated CNA 3's hire date was 12/14/2022 and
her last competency skills check was done on 10/26/2023. The DSD stated the competency skills check for
the year 2024 was not done for CNA 3. During an interview on 7/2/2025 at 9:24 a.m. with the DSD, the DSD
stated competency skills check, and performance reviews should be in the employee files and completed.
The DSD stated the completion of competency skills is to show proof that their nurses, licensed nurses and
CNAs, have the skills and ability to perform patient care, medication administration, lift machine, and do
their job description. The DSD stated it should be filed immediately. DSD stated it should have been
completed during day 1 and 2 of orientation. The DSD stated if it is not filed, she would not know if it was
completed. During an interview on 7/3/2025 at 8:51 a.m. with the Director of Nursing (DON), the DON
stated performance reviews are done yearly including CNAs. The DON stated they know what their
responsibilities and expectations are based on their job description. The DON stated competency is done
yearly and if there was a deficiency they would do another competency. The DON stated this is done to
ensure that licensed nurses and CNAs know how to provide the care and treatment they are providing. The
DON stated the residents may cause injury to the residents such as transferring residents and may cause
injury when transfer and staff can injure themselves when taking care of residents. During a review of the
facility's policy and procedure (P&P) titled, Job Descriptions and Performance Evaluations, last reviewed
1/2025, the P&P indicated that each employee will receive a copy of his/her respective job description prior
to his/her performance of assigned tasks. The P&P indicated the primary purpose of the facility's job
description and performance evaluations is to provide uniform guidelines for the implementation of job
requirements and the evaluation of the standards of job performance. The P&P indicated the objectives of
the facility's job descriptions and performance evaluations are to: a. Clarify who is responsible for particular
duties within their facility; b. Assist employees in understanding the essential functions, responsibilities,
working conditions, qualifications, and specific physical requirements of their positions; c. Prevent
misunderstanding about job responsibilities and how each job is evaluated; e. Provide a basis for job
evaluation, wage and salary increases, promotions, demotions, transfers, etc. and to improve the quality of
work performance.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 31 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation interview, and record review, the facility failed to provide pharmaceutical services (including
procedures that assure the accurate acquiring, receiving, dispensing, and administering of all drugs and
biologicals) for two of five sampled residents (Resident 36 and 31), by failing to: 1.Ensure Licensed
Vocational Nurse (LVN) 5 administered medication per the physician prescribed orders when LVN 5 omitted
(did not administer) amiodarone (medication to prevent and treat certain types of serious heart rhythm
problems) and famotidine (a medication that reduces stomach acid production) on 7/2/2025 during the 9
a.m. medication pass observation for Resident 36. 2.Ensure LVN 5 did not document the administration of
omitted medications amiodarone and famotidine in the resident's medication administration record (MAR a daily documentation record used by a licensed nurse to document medications and treatments given to a
resident) on 7/2/2025 during the 9 a.m. medication pass observation for Resident 36. 3.Monitor hemoglobin
(a protein in red blood cells that carry oxygen) levels before the administration of Epogen (a medication
used to treat anemia [a condition where the body does not have enough healthy red blood cells] by creating
more blood cells for Resident 31. These deficient practices had the potential to result in a delay of care and
treatment, mismanagement of residents' care, and miscommunication among caregivers. Cross Reference
to F757 and F759 Findings: 1.During a review of Resident 36’s admission Record (AR), the AR
indicated the facility originally admitted the resident on 8/16/2024 and most recently admitted the resident
on 11/8/2024 with diagnoses that included metabolic encephalopathy a (general term that describes brain
disease, damage, or malfunction usually related to inflammation within the body), dysphagia (difficulty
swallowing), hypertensive heart disease with heart failure (refers to heart problems that occur because of
high blood pressure that is present over a long time), anxiety disorder (a mental health condition that may
result in restlessness, irritability, feelings of nervousness, panic, and fear), depression (persistent feelings of
sadness and loss of interest that can interfere with daily living), presence of cardiac pacemaker (a small
battery-operated device that helps the heart beat in a regular rhythm), and presence of gastrostomy tube
[GT or G-tube, a tube that is inserted into the stomach).
During a review of Resident 36’s Minimum Data Set (MDS – resident assessment tool) dated
5/7/2025, the MDS indicated the resident usually was able to understand others and usually was able to
make themself understood. The MDS further indicated the resident was dependent on staff for dressing,
personal and oral hygiene, toileting, bathing, and mobility.
During a review of Resident 36’s Order Summary Report, the Order Summary Report indicated the
following physician orders:
1.Amiodarone HCl Oral Tablet 100 milligrams (mg, a unit of measurement) Give 100 mg via G-Tube two
times a day for arrhythmia (an irregular heart rhythm) hold (do not give) for heart rate (HR) less than (<)
60 beats per minute (BPM), dated 2/18/2025.
2.Arginine (a supplement that helps the body produce proteins) Oral Packet, give 1 packet via G-Tube two
times a day for supplement, dated 2/18/2025.
3.Buspirone (an anti-anxiety medication) HCl Oral Tablet 5 mg, give 1 tablet via G-Tube two times a day for
anxiety manifested by (m/b) physical restlessness as evidenced by (AEB) thrashing back and forth in bed,
dated 5/26/2025.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 32 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
4.Apixaban (medication used to treat and prevent blood clots [gel-like clumps of blood]) Oral Tablet five (5)
mg, give 1 tablet via G-Tube two times a day for deep vein thrombosis (a serious condition where a blood
clot forms in a deep vein), monitor for bleeding, dated 02/18/2025.
5.Clonazepam (medication to prevent and treat anxiety disorders) Oral Tablet 1 mg, give 1 tablet via G-Tube
two times a day for anxiety with agitation m/b physical restlessness AEB trashing back and forth in bed,
dated 02/18/2025.
6.Risperidone (medication used to treat mental disorders) Oral Tablet, give 1.5 mg via G-Tube two times a
day for psychosis m/b disrobing, self-harm behaviors AEB throwing self on floor.
7.Sennoside (medication used to treat constipation) Oral Tablet 8.6 mg, give two tablets via G-Tube two
times a day for severe constipation if no bowel movement for 4 days. Hold for loose stools, dated
02/18/2025.
8.Famotidine (used to prevent and treat heartburn due to acid indigestion Oral Tablet 20 mg, give 20 mg via
G-Tube every 12 hours for gastrointestinal (the organs and system involved in digestion) prophylaxis, dated
02/18/2025.
During a Medication Administration Observation on 7/2/2025 at 8 a.m., with LVN 5, observed LVN 5
prepare Resident 36’s medications at Station 1 Medication Cart. Observed LVN 5 removed
amiodarone from the bubble pack (a package that contains multiple sealed compartments with medication),
reviewed the physician’s order, and then stated the amiodarone was already given by the night shift
nurse. Observed LVN 5 place the amiodarone in the medication waste bin. Observed LVN 5 then prepared
cups for water flush, and the following supplement and medications to administer via GT:
1.Arginine one oral powder packet
2.Buspirone, one 5 mg tablet
3.Apixaban, one 5 mg tablet
4.Clonazepam, one 1 mg tablet
5.Risperidone one 1.5 mg tablet
6.Sennoside, two 8.6 mg tablets
LVN 5 entered Resident 36’s room and administered the water flushes and arginine, buspirone,
apixaban, clonazepam, risperidone, and sennoside to the resident via GT. LVN 5 exited Resident
36’s room and stated LVN 5 would now document the administration of Resident 36’s
medication in the MAR on the computer. LVN 5 stated LVN 5 administered the supplement and five 9 a.m.
medications to Resident 36.
During a follow-up concurrent interview and record review on 7/2/2025 at 11:19 a.m. with LVN 5, LVN 5
reviewed Resident 36’s MAR for 7/2/2025 and physician orders and noted the following:
-Resident 36 had an order for famotidine to be administered during the 9 a.m. medication pass. LVN 5 did
not administer famotidine to Resident 36. LVN 5 documented in the MAR that LVN 5 administered
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 33 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
famotidine to Resident 36.
Level of Harm - Minimal harm
or potential for actual harm
-Resident 36 had an order for amiodarone to be administered during the 9 a.m. medication pass. LVN 5 did
not administer amiodarone to Resident 36. LVN 5 documented in the MAR that LVN 5 administered
amiodarone to Resident 36. There was no documented evidence that the night shift administered
amiodarone to Resident 36.
Residents Affected - Some
LVN 5 further stated that LVN 5 did not administer amiodarone because LVN 5 was confused. LVN 5 stated
LVN 5 did not administer famotidine because the medication was not in the Station 1 Medication Cart. LVN
5 stated LVN 5 accidentally documented that LVN 5 administered amiodarone and famotidine to Resident
36. LVN 5 stated that when LVN 5 was confused and did not find the medication in the medication cart, LVN
5 should have gone to a supervisor, but LVN 5 did not. LVN 5 stated when LVN 5 documented the
administration of amiodarone and famotidine in Resident 36’s MAR, the medication was considered
given. LVN 5 stated if an administration is documented, then it is considered done. LVN 5 stated Resident
36’s MAR was not accurate. LVN 5 stated it was important for the care of the resident to administer
all resident medications per the physician’s orders. LVN 5 stated LVN 5 made a mistake and would
administer the famotidine and amiodarone to Resident 36.
During a concurrent interview and record review on 7/2/2025 at 1:40 p.m. Registered Nurse (RN) 1
reviewed the facility policy and procedure (P&P) regarding medication administration and documentation.
RN 1 stated the medication administration process is to administer medications per the physician’s
orders and then document in the MAR. RN 1 stated LVN 5 probably just clicked and clicked to document in
the MAR, but LVN 5 did not administer all the medication. RN 1 stated it was a medication error when LVN
5 did not administer amiodarone and famotidine to Resident 36 and documented the medication as
administered. RN 1 stated when Resident 36 did not receive amiodarone there was a potential that the
resident would have atrial fibrillation (an irregular and often very rapid heart rhythm that can lead to blood
clots) or other heart issues. RN 1 stated when Resident 36 did not receive famotidine there was a potential
that Resident 36 would have abdominal pain. RN 1 stated LVN 5 did not follow the facility P&Ps.
During a review of the facility P&P titled, “Administering Medications,” last reviewed 1/2025,
the P&P indicated medications are administered in a safe and timely manner, and as prescribed. Only
persons licensed or permitted by this state to prepare, administer, and document the administration of
medications may do so. Medications are administered in accordance with prescriber orders, including any
required time frame. Medications are administered within one (I) hour of their prescribed time, unless
otherwise specified (for example, before and after meal orders). If a drug is withheld, refused, or given at a
time other than the scheduled time, the individual administering the medication shall initial and circle the
MAR space provided for that drug and dose. The individual administering the medication must initial the
resident's MAR on the appropriate line after giving each medication and before administering the next
ones. As required or indicated for a medication, the individual administering the medication will record in the
resident's medical record: The date and time the medication was administered.
During a review of the facility P&P titled, “Adverse Consequences and Medication Errors,”
last reviewed 1/2025, the P&P indicated a medication error is defined as the preparation or administration
of drugs or biological which is not in accordance with physician's orders, manufacturer specifications, or
accepted professional standards and principles of the professional(s) providing services. Examples of
medications errors include:
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 34 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
-Omission - a drug is ordered but not administered.
Level of Harm - Minimal harm
or potential for actual harm
-Wrong time.
Residents Affected - Some
2. During a review of Resident 31’s AR, the AR indicated the facility admitted Resident 31 on
4/25/2025 and readmitted on [DATE] with diagnoses including end stage renal disease (ESRD-irreversible
kidney failure), chronic obstructive pulmonary disease (COPD-a chronic lung disease causing difficulty in
breathing), and anemia.
During a review of Resident 31’s MDS dated [DATE], the MDS indicated Resident 31’s
cognitive functioning (mental processes that enable people to think, understand, make decisions, and
complete tasks) was moderately impaired. The MDS also indicated Resident 31 required moderate
assistance with oral hygiene, personal hygiene, and maximal assistance with toileting hygiene, showers,
and chair to bed transfers.
During a review of Resident 31’s Order Summary Report, the Order Summary Report indicated the
following physician’s order:
-5/27/2025: Epogen (Epoetin Alfa) Injection Solution 10000 unit/milliliter (unit/ml-unit of measurement).
Inject 1 dose subcutaneously (beneath the skin) one time a day every Tuesday for anemia. Hold if
hemoglobin is greater (>) than 11.
During a concurrent interview and record review on 7/2/2015 at 3:05 p.m. with RN 1, Resident 31’s
MAR, dated 6/2025 was reviewed. The MAR indicated, on 6/3/2025 for the 9 a.m. administration time and
6/10/2025 for the 9 a.m. administration time, there were licensed staff initials in the box for Resident
31’s Epogen Injection Solution, indicating the medication was administered. RN 1 stated Resident
31’s hemoglobin levels have not been monitored since resident’s admission to the facility. RN
1 stated Epogen should not have been administered without checking hemoglobin levels and there was a
potential for Resident 31 to receive Epogen when Resident’s hemoglobin level was >11. RN 1
stated Resident 31’s hemoglobin levels should have been monitored every week prior to medication
administration. RN 1 stated the failure to monitor hemoglobin levels could potentially cause Resident 31 to
experience liver problems.
During an interview on 7/2/2025 at 3:35 p.m. with the Director of Nursing (DON), the DON stated Resident
31’s hemoglobin level should have been monitored every week prior to administration of Epogen.
The DON stated the failure to monitor hemoglobin levels prior to administering Epogen had the potential to
cause polycythemia (high hemoglobin concentration in the blood) in Resident 31 negatively affecting
resident’s well-being.
During a review of the facility provided manufacturer’s guideline for Epogen dated 9/2017, the
guideline indicated to monitor hemoglobin levels at least weekly until stable, then monitor at least monthly
for CKD patients. The manufacturer’s guideline also indicated there is a greater risk for adverse
cardiovascular reactions, and stroke when Epogen is administered to target a hemoglobin level of greater
than 11grams/deciliter (g/dL-unit of volume measurement).
During a review of the facility-provided P&P titled, “Administering Medications,” last reviewed
on 01/2025, the P&P indicated, “Medications shall be administered in a safe and timely manner, and
as prescribed.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 35 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview, and record review, the facility failed to ensure residents were free of unnecessary medication for
one of one sampled residents (Residents 31) by failing to monitor Resident 31's hemoglobin (a protein in
red blood cells that carry oxygen) levels to ensure Epogen (a medication used to treat anemia [a condition
where the body does not have enough healthy red blood cells] by creating more blood cells) was indicated
for Resident 31 prior to the administration of the medication. This deficient practice had the potential for
Resident 31 to experience adverse (unwanted, unintended result) cardiovascular (heart and blood vessels)
reactions and stroke (loss of blood flow to a part of the brain). Cross Reference with F755 Findings: During
a review of Resident 31's admission Record (AR), the AR indicated the facility admitted Resident 31 on
4/25/2025 and readmitted on [DATE] with diagnoses including end stage renal disease (ESRD-irreversible
kidney failure), chronic obstructive pulmonary disease (COPD-a chronic lung disease causing difficulty in
breathing), and anemia. During a review of Resident 31's Minimum Data Set (MDS-resident assessment
tool), dated 4/30/2025, the MDS indicated Resident 31's cognitive functioning (mental processes that
enable people to think, understand, make decisions, and complete tasks) was moderately impaired. The
MDS also indicated Resident 31 required moderate assistance with oral hygiene, personal hygiene, and
maximal assistance with toileting hygiene, showers, and chair to bed transfers. During a review of Resident
31's Order Summary Report, the Order Summary Report indicated the following physician's order:
-5/27/2025: Epogen (Epoetin Alfa) Injection Solution 10000 unit/milliliter (unit/ml-unit of measurement).
Inject 1 dose subcutaneously (beneath the skin) one time a day every Tuesday for anemia. Hold if
hemoglobin is greater (>) than 11. During a concurrent interview and record review on 7/2/2015 at 3:05
p.m. with Registered Nurse (RN) 1, Resident 31's Medication Administration Record (MAR), dated 6/2025
was reviewed. The MAR indicated, on 6/3/2025 for the 9 a.m. administration time and 6/10/2025 for the 9
a.m. administration time, there was a licensed staff initials in the box for Resident 31's Epogen Injection
Solution, indicating the medication was administered. RN 1 stated Epogen should not have been
administered without monitoring of the hemoglobin levels. RN 1 stated Resident 31's hemoglobin levels
should have been monitored every week prior to medication administration. RN 1 stated the failure to
monitor hemoglobin levels could potentially cause Resident 31 to receive Epogen when hemoglobin level
was high and the medication was not indicated. RN 1 stated this failure had the potential for Resident 31 to
experience liver problems. During an interview on 7/2/2025 at 3:35 p.m. with the Director of Nursing (DON),
the DON stated Resident 31's hemoglobin level should have been monitored every week prior to
administration of Epogen. The DON stated the failure to monitor hemoglobin levels prior to administering
Epogen had the potential to cause polycythemia (high hemoglobin concentration in the blood) in Resident
31 negatively affecting her well-being. During a review of the facility provided manufacturer's guideline for
Epogen dated 9/2017, the guideline indicated to monitor hemoglobin levels at least weekly until stable, then
monitor at least monthly for CKD patients. The manufacturer's guideline also indicated there is a greater
risk for adverse cardiovascular reactions, and stroke when Epogen is administered to target a hemoglobin
level of greater than 11grams/deciliter (g/dL-unit of volume measurement). During a review of the
facility-provided policy and procedure (P&P) titled, Administering Medications, last reviewed on 01/2025,
the P&P indicated, Medications shall be administered in a safe and timely manner, and as prescribed.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 36 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Ensure medication error rates are not 5 percent or greater.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review, the facility failed to ensure that its medication error rate
was less than five (5) percent (% - out of one hundred). Two (2) medication errors out of 29 total
opportunities contributed to an overall medication error rate of 6.9% affecting one (1) of five (5) residents
observed for medication administration (Resident 36). The medication errors resulted when the facility failed
to: 1.Ensure Licensed Vocational Nurse (LVN) 5 administered medication per the physician prescribed
orders when LVN 5 omitted (did not administer) amiodarone (medication to prevent and treat certain types
of serious heart rhythm problems) and famotidine (a medication that reduces stomach acid production) on
7/2/2025 during the 9 a.m. medication pass observation. 2.Ensure LVN 5 did not document the
administration of omitted medications amiodarone and famotidine in Resident 36's medication
administration record (MAR - a daily documentation record used by a licensed nurse to document
medications and treatments given to a resident) on 7/2/2025 during the 9 a.m. medication pass
observation. These deficient practices had the potential to result in a delay of care and treatment,
mismanagement of resident's care, and miscommunication among caregivers. Cross Reference to F755
Findings: During a review of Resident 36's admission Record (AR), the AR indicated the facility originally
admitted the resident on 8/16/2024 and most recently admitted the resident on 11/8/2024 with diagnoses
that included metabolic encephalopathy a (general term that describes brain disease, damage, or
malfunction usually related to inflammation within the body), dysphagia (difficulty swallowing), hypertensive
heart disease with heart failure (refers to heart problems that occur because of high blood pressure that is
present over a long time), anxiety disorder (a mental health condition that may result in restlessness,
irritability, feelings of nervousness, panic, and fear), depression (persistent feelings of sadness and loss of
interest that can interfere with daily living), presence of cardiac pacemaker (a small battery-operated device
that helps the heart beat in a regular rhythm), and presence of gastrostomy tube [GT or G-tube, a tube that
is inserted into the stomach). During a review of Resident 36's Minimum Data Set (MDS - resident
assessment tool), dated 5/7/2025, the MDS indicated the resident usually was able to understand others
and usually was able to make themself understood. The MDS further indicated the resident was dependent
on staff for dressing, personal and oral hygiene, toileting, bathing, and mobility. During a review of Resident
36's Order Summary Report, the Order Summary Report indicated the following physician orders:
1.Amiodarone HCl Oral Tablet 100 milligrams (mg, a unit of measurement) Give 100 mg via G-Tube two
times a day for arrhythmia (an irregular heart rhythm) hold (do not give) for heart rate (HR) less than (<)
60 beats per minute (BPM), dated 2/18/2025. 2.Arginine (a supplement that helps the body produce
proteins) Oral Packet, give 1 packet via G-Tube two times a day for supplement, dated 2/18/2025.
3.Buspirone (an anti-anxiety medication) HCl Oral Tablet 5 mg, give 1 tablet via G-Tube two times a day for
anxiety manifested by (m/b) physical restlessness as evidenced by (AEB) thrashing back and forth in bed,
dated 5/26/2025. 4.Apixaban (medication used to treat and prevent blood clots [gel-like clumps of blood])
Oral Tablet five (5) mg, give 1 tablet via G-Tube two times a day for deep vein thrombosis (a serious
condition where a blood clot forms in a deep vein), monitor for bleeding, dated 02/18/2025. 5.Clonazepam
(medication to prevent and treat anxiety disorders) Oral Tablet 1 mg, give 1 tablet via G-Tube two times a
day for anxiety with agitation m/b physical restlessness AEB trashing back and forth in bed, dated
02/18/2025. 6.Risperidone (medication used to treat mental disorders) Oral Tablet, give 1.5 mg via G-Tube
two times a day for psychosis m/b disrobing, self-harm behaviors AEB throwing self on floor 7.Sennoside
(medication used to treat constipation) Oral Tablet 8.6 mg, give two tablets via G-Tube two times a day for
severe constipation if no bowel movement for 4 days. Hold for loose stools, dated 02/18/2025.
Residents Affected - Few
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 37 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
8.Famotidine (used to prevent and treat heartburn due to acid indigestion Oral Tablet 20 mg, give 20 mg via
G-Tube every 12 hours for gastrointestinal (the organs and system involved in digestion) prophylaxis, dated
02/18/2025. During a Medication Administration Observation on 7/2/2025 at 8 a.m., with LVN 5, observed
LVN 5 prepare Resident 36's medications at Station 1 Medication Cart. Observed LVN 5 removed
amiodarone from the bubble pack (a package that contains multiple sealed compartments with medication),
reviewed the physician's order, and then stated the amiodarone was already given by the night shift nurse.
Observed LVN 5 place the amiodarone in the medication waste bin. Observed LVN 5 then prepared cups
for water flush, and the following supplement and medications to administer via GT: 1.Arginine one oral
powder packet 2.Buspirone, one 5 mg tablet 3.Apixaban, one 5 mg tablet 4.Clonazepam, one 1 mg tablet
5.Risperidone one 1.5 mg tablet 6.Sennoside, two 8.6 mg tablets LVN 5 entered Resident 36's room and
administered the water flushes and arginine, buspirone, apixaban, clonazepam, risperidone, and sennoside
to the resident via GT. LVN 5 exited Resident 36's room and stated LVN 5 would now document the
administration of Resident 36's medication in the MAR on the computer. LVN 5 stated LVN 5 administered
the supplement and five 9 a.m. medications to Resident 36. During a follow-up concurrent interview and
record review on 7/2/2025 at 11:19 a.m. with LVN 5, LVN 5 reviewed Resident 36's MAR for 7/2/2025 and
physician orders and noted the following: -Resident 36 had an order for famotidine to be administered
during the 9 a.m. medication pass. LVN 5 did not administer famotidine to Resident 36. LVN 5 documented
in the MAR that LVN 5 administered famotidine to Resident 36. -Resident 36 had an order for amiodarone
to be administered during the 9 a.m. medication pass. LVN 5 did not administer amiodarone to Resident 36.
LVN 5 documented in the MAR that LVN 5 administered amiodarone to Resident 36. There was no
documented evidence that the night shift administered amiodarone to Resident 36. LVN 5 further stated
that LVN 5 did not administer amiodarone because LVN 5 was confused. LVN 5 stated LVN 5 did not
administer famotidine because the medication was not in the Station 1 Medication Cart. LVN 5 stated LVN 5
accidentally documented that LVN 5 administered amiodarone and famotidine to Resident 36. LVN 5 stated
that when LVN 5 was confused and did not find the medication in the medication cart, LVN 5 should have
gone to a supervisor, but LVN 5 did not. LVN 5 stated when LVN 5 documented the administration of
amiodarone and famotidine in Resident 36's MAR, the medication was considered given. LVN 5 stated if an
administration is documented, then it is considered done. LVN 5 stated Resident 36's MAR was not
accurate. LVN 5 stated it was important for the care of the resident to administer all resident medications
per the physician's orders. LVN 5 stated LVN 5 made a mistake and would administer the famotidine and
amiodarone to Resident 36. During a concurrent interview and record review on 7/2/2025 at 1:40 p.m.
Registered Nurse (RN) 1 reviewed the facility policy and procedure (P&P) regarding medication
administration and documentation. RN 1 stated the medication administration process is to administer
medications per the physician's orders and then document in the MAR. RN 1 stated LVN 5 probably just
clicked and clicked to document in the MAR, but LVN 5 did not administer all the medication. RN 1 stated it
was a medication error when LVN 5 did not administer amiodarone and famotidine to Resident 36 and
documented the medication as administered. RN 1 stated when Resident 36 did not receive amiodarone
there was a potential that the resident would have atrial fibrillation (an irregular and often very rapid heart
rhythm that can lead to blood clots) or other heart issues. RN 1 stated when Resident 36 did not receive
famotidine there was a potential that Resident 36 would have abdominal pain. RN 1 stated LVN 5 did not
follow the facility P&Ps. During a review of the facility P&P titled, Administering Medications, last reviewed
1/2025, the P&P indicated medications are administered in a safe and timely manner, and as prescribed.
Only persons licensed or permitted by this state to prepare, administer, and document the
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 38 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
administration of medications may do so. Medications are administered in accordance with prescriber
orders, including any required time frame. Medications are administered within one (I) hour of their
prescribed time, unless otherwise specified (for example, before and after meal orders). If a drug is
withheld, refused, or given at a time other than the scheduled time, the individual administering the
medication shall initial and circle the MAR space provided for that drug and dose. The individual
administering the medication must initial the resident's MAR on the appropriate line after giving each
medication and before administering the next ones. As required or indicated for a medication, the individual
administering the medication will record in the resident's medical record: The date and time the medication
was administered. During a review of the facility P&P titled, Adverse Consequences and Medication Errors,
last reviewed 1/2025, the P&P indicated a medication error is defined as the preparation or administration
of drugs or biological which is not in accordance with physician's orders, manufacturer specifications, or
accepted professional standards and principles of the professional(s) providing services. Examples of
medications errors include: -Omission - a drug is ordered but not administered. -Wrong time.
Event ID:
Facility ID:
555132
If continuation sheet
Page 39 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure residents were free of any significant medication
errors (means the observed or identified preparation or administration of medications or biologicals which is
not in accordance with the prescriber's order, manufacturer's specifications, and accepted professional
standards) for one of one sampled resident (Resident 25) by failing to ensure subcutaneous (beneath the
skin) insulin (a hormone that lowers the level of glucose [a type of sugar] in the blood) administration sites
were rotated (a method to ensure repeated injections are not administered in the same area). Cross
Reference F658. Findings: During a review of Resident 25's admission Record (AR), the AR indicated the
facility admitted Resident 25 on 8/31/2016 and readmitted on [DATE] with diagnoses including diabetes
mellitus (DM-a disorder characterized by difficulty in blood sugar control and poor wound healing), chronic
obstructive pulmonary disease (COPD-a chronic lung disease causing difficulty in breathing, and
congestive heart failure (CHF-a heart disorder which causes the heart to not pump the blood efficiently,
sometimes resulting in leg swelling). During a review of Resident 25's History and Physical (H&P), dated
10/25/2024, the H&P indicated, Resident 25 had the capacity to understand and make decisions. During a
review of Resident 25's Minimum Data Set (MDS-resident assessment tool), dated 5/9/2025, the MDS
indicated Resident 25's cognitive functioning (mental processes that enable people to think, understand,
make decisions, and complete tasks) was intact. The MDS also indicated Resident 25 required supervision
with showers, bed to chair transfers, and toilet transfers. During a review of Resident 25's Order Summary
Report, the Order Summary Report indicated the following physician's order: -2/9/2025: Insulin Glargine
(Lantus SoloStar- a long-acting insulin that provides a consistent level of insulin in the body over
approximately 24 hours) Subcutaneous Solution Pen-Injector (a medical device designed for easy and
accurate administration of injectable medication) 100 unit per milliliter (unit/ml - a unit of measurement).
Inject 90 units subcutaneously in the morning. Rotate Site. Hold if blood sugar (BS-body's main source of
energy) is less than 100. During a concurrent interview and record review on 7/2/2015 at 2:50 p.m. with
Licensed Vocational Nurse (LVN) 4, Resident 25's Medication Administration Record (MAR), dated 6/2025
was reviewed. The MAR indicated, the MAR indicated the insulin glargine was administered as follows:
6/4/25 06:00 6/4/25 06:27 subcutaneously Abdomen-left upper quadrant (LUQ) 6/5/25 06:00 6/5/25 06:13
subcutaneously Abdomen- LUQ 6/6/25 06:00 6/6/25 05:20 subcutaneously Arm-right 6/7/25 06:00 6/7/25
05:52 subcutaneously Arm-right 6/15/25 06:00 6/15/25 05:18 subcutaneously Abdomen-left lower quadrant
(LLQ) 6/16/25 06:00 6/16/25 06:13 subcutaneously Abdomen-LLQ 6/17/25 06:00 6/17/25 06:01
subcutaneously Abdomen-LLQ 6/20/25 06:00 6/20/25 06:33 subcutaneously Abdomen-LLQ 6/21/25 06:00
6/21/25 05:11 subcutaneously Abdomen-LLQ LVN 4 stated the insulin administration sites should have
been rotated during each administration. LVN 4 stated the failure to rotate insulin administration sites had
the potential for Resident 25 to experience skin problems, adverse effects and affect the absorption of the
insulin. During an interview on 7/2/2025 at 3:05 p.m. with Registered Nurse (RN) 1, RN 1 stated licensed
staff should have rotated insulin administration sites. RN 1 stated the failure to rotate insulin administration
sites was considered a medication error and had the potential to damage Resident 25's subcutaneous
tissue. During an interview on 7/3/2025 at 12:26 p.m. with the Director of Nursing (DON), the DON stated
insulin administration sites should be rotated. The DON stated the failure to rotate insulin administration
sites was a medication error and had the potential to cause cellulitis (a skin infection that causes swelling
and redness), damage the subcutaneous tissue and affect the absorption of the medication. During a
review of the facility provided manufacturer's guideline for Lantus dated 8/2022, the guideline
Residents Affected - Few
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 40 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
indicated to rotate injection sites to reduce the risk of lipodystrophy and localized cutaneous amyloidosis at
the injection site. During a review of the facility-provided policy and procedure (P&P) titled, Insulin
Administration, last reviewed on 01/2025, the P&P indicated, Injection sites should be rotated, preferably in
the same general area (abdomen, thigh, upper arm). During a review of the facility-provided policy and
procedure (P&P) titled, Medication Administration, last reviewed on 01/2025, the P&P indicated,
Medications must be administered in accordance with the orders, including any required time frame. During
a review of the facility-provided policy and procedure (P&P) titled, Adverse Consequences and Medication
Errors, last reviewed on 01/2025, the P&P indicated, A ‘medication error' is defined as the preparation or
administration of drugs or biological which is not in accordance with physician's orders, manufacturer
specifications, or accepted professional standards and principles of the professional(s) providing services.
Event ID:
Facility ID:
555132
If continuation sheet
Page 41 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0803
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Ensure menus must meet the nutritional needs of residents, be prepared in advance, be followed, be
updated, be reviewed by dietician, and meet the needs of the resident.
Based on observation, interview, and record review, the facility failed to follow the menu and did not meet
nutritional needs of residents when [NAME] 1 did not level the number eight (8) scoop (1/2 cup [c, a unit of
measurement]) for serving egg noodles. This failure had the potential to result in excess food served
resulting to increased nutrient intake of 64 of 69 resident who received egg noodles causing unintended
weight gain and ineffective therapeutic diet provisions of 16 of 20 residents on consistent carbohydrate diet
(CCHO, a diet with the same amount of carbohydrate [macronutrient found in many foods and drinks,
including sugars, starches, and fiber] each meal to manage high blood sugar). Findings: During a review of
the facility's daily spreadsheet (a list of food, amount of food that each diet would receive) titled, Menus,
dated 6/30/2025, the spreadsheet indicated residents on regular diet (diet with no restriction) and CCHO
would include the following foods on the tray: -Swedish meatballs two (2) pieces -Gravy 1-2 ounces (oz, a
unit of measurement) -Egg noodles 1/2 cup (c, a household measurement) -Fresh zucchini and carrots 1/2
c -Orange slice 1 -Wheat rolls 1 pc -Margarine 1 teaspoon -Raspberry parfait 2x2 1/2 inch (regular diet)
-Diet gelatin with 1 tablespoon of whip cream (for CCHO diet) -Milk 2 oz During an observation on
6/30/2025 at 12:10 p.m. of the trayline (an area where foods were assembled from the steamtable to
resident's plate), observed [NAME] 1 using number 8 scoop to portion the egg noodles to the plate and it
was overflowing. During a concurrent observation and interview on 6/30/2025 with the Dietary Supervisor
(DS) at the trayline area, observed [NAME] 1 portioning egg noodles using number 8 scoop. The DS stated
[NAME] 1 used number 8 scoop in portioning egg noodles, it was not leveled, and it should be leveled. The
DS stated [NAME] 1 gave too much egg noodles on the trays that could potentially cause unintended
weight gain to the residents. During a review of the facility's policies and procedures (P&P) titled, Food
Preparation, dated 1/5/2025, the P&P indicated, PROCEDURE: (1) The facility will use approved recipes,
standardized to meet the resident census. This count is to be kept current so that an accurate amount of
food is prepared. (2) Recipes are specific as to portion yield, method of preparation, amounts of
ingredients, and time and temperature guide. During a review of the facility's P&P titled, Portion Sizes,
dated 1/5/2025, the P&P indicated POLICY: Various portion sizes of food served will be available to better
meet the needs of the residents. PROCEDURE: The small or large portion servings will be served as
printed on the cook's spreadsheets for every meal. During a review of the facility's standardized recipe
titled, RECIPE: EGG NOODLES, dated 2024, the recipe indicated portion size: 1/2 cup.
Event ID:
Facility ID:
555132
If continuation sheet
Page 42 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0805
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure each resident receives and the facility provides food prepared in a form designed to meet individual
needs.
Based on observation, interview, and record review, the facility failed to prepare food in a form designed to
meet individual needs when puree (foods that are smooth with pudding like consistency) pasta was too dry,
puree vegetables were watery, and puree meat did not hold its shape on the plate. These failures had the
potential to result in difficulty in swallowing, chewing, decrease in food intake and nutrient intake to 9 of 9
residents on puree diet, resulting in unintended (not planned) weight loss and choking (when food gets
stuck in your airway, blocking the flow of air to your lungs). Findings: During a review of the facility's menu
spreadsheet (a sheet containing the kind and amount of food each diet would receive) titled, Menus, dated
6/30/2025, the spreadsheet indicated residents on puree diet would include the following foods on the tray:
-Puree Swedish meatballs 1/2 cup (c., household measurement) with gravy -Puree egg noodles 1/2 c
-Puree fresh zucchini and carrots 1/3 c. -Puree orange slice 1-2/3 teaspoon -Puree wheat roll 1/4 c -Puree
raspberry parfait 1/3 c -Milk 4 ounces (oz, a unit of measurement) -Puree pound cake with fresh
strawberries 1/2 c/1 tablespoon During an observation on 6/30/2025 at 11:58 a.m. of puree food
preparation, observed [NAME] 1 used a blender. During an observation on 6/30/2025 at 12:00 p.m. of puree
food preparation, observed [NAME] 1 pouring thickener in the puree vegetable without measuring it. During
an observation on 6/30/2025 at 12:10 p.m. of puree pasta, observed puree pasta had particles and puree
Swedish meatballs did not hold its shape when plated on the plate. During a concurrent test tray (a process
of tasting, temping, and evaluating the quality of food) observation and interview on 6/30/2025 at 1:03 p.m.
with the Dietary Supervisor (DS), observed the puree meat did not hold its shape on the plate and was flat,
puree fresh zucchini and carrots had liquid coming out on the side and puree egg noodles were dry. The
DS stated a puree diet should be presentable, not too watery but not too dry and food should hold its shape
on the plate. The DS stated the puree Swedish meatballs did not hold it shape on the plate and the puree
zucchini and carrots had liquid coming out on the side. The DS further stated the puree egg noodle was not
pudding like consistency because it was a little dry. The DS stated residents would have a hard time
swallowing resulting in choking as a potential outcome and the food presentation was affected. The DS
stated the residents would not eat the food and would lead to weight loss as a potential outcome. During a
review of the facility's policies and procedures titled, Menu Planning, dated 1/2025, the P&P indicated
Procedures: (1) The facilities' diet manual and the diets ordered by the physician should mirror the
nutritional care provided by the facility. (4) Standardized recipes adjusted to appropriate yield shall be
maintained and used in food preparation. During a review of the facility's P&P titled, Diet Manual, dated
2020, the P&P indicated, This diet manual is designed to meet the specific needs of intermediary and
long-term care facilities. Objectives: (1) To provide a realistic approach to diets in order to make them
adaptable and flexible to the individual needs and cultural background of the residents. (2) To meet the
most recent Recommended Dietary Allowances. The RDA's were used as a basis for determining the
adequacy of the diets. It must be recognized that all these allowances were developed for the maintenance
of good nutrition in healthy individuals. A resident may require more or less of these nutrients. (3) To have a
common language of communication among Food and Nutrition Services, Nursing, Physicians, Residents
and their families. During a review of the facility's diet manual (a manual containing different diets
descriptions, foods allowed and avoided and sample menus the facility have) titled Regular Pureed Diet
dated 2020, the diet manual indicated The pureed diet is a regular diet that has been designed for residents
who have difficulty chewing and or swallowing. The texture of the food should be of a smooth and moist
consistency and able to hold its shape. Detailed procedure of pureeing food is in Binder
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 43 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0805
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
#1, misc. section. All foods are prepared in a food processor or blender, with the exception of foods which
are normally in a soft, and smooth state such as pudding, ice cream, applesauce, mashed potato, etc.
During a review of the facility's standardized recipe titled Recipe: Pureed (IDDSI Level 4) Meats dated
2024, the recipe indicated (5) The finished pureed item should be smooth and free of lumps, hold it shape,
while not being firm or sticky, and should not weep. The finished puree item must pass IDDSI level 5 testing
requirements (i.e. the fork drip, fork pressure, and spoon tilt tests). During a review of the facility's
standardized recipe title Recipe: Pureed (IDSSI Level 4) Vegetables dated 2024, the recipe indicated (5)
The finished pureed item should be smooth and free of lumps, hold it shape, while not being firm or sticky,
and should not weep. The finished puree item must pass IDDSI level 5 testing requirements (i.e. the fork
drip, fork pressure, and spoon tilt tests). During a review of the IDDSI guideline website titled IDDSI, dated
7/2019, the IDSSI guideline indicated, Level 4 Pureed is usually eaten with spoon, falls off spoon in a single
spoonful when tilted and continues to hold shape on the plate, no lumps, not sticky, and liquid must not
separate from solid. Food testing method: Spoon tilt test and fork drip test.
Event ID:
Facility ID:
555132
If continuation sheet
Page 44 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0806
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure each resident receives and the facility provides food that accommodates resident allergies,
intolerances, and preferences, as well as appealing options.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to ensure that one (1) of 1 sampled resident
(Resident 40) food allergy, food preferences and intolerances were honored when orange slices, cheese
quesadilla and pasta were served at lunch on 6/30/2025. Resident 40 was allergic to oranges, had
intolerances to milk and milk products and disliked pasta. This deficient practice resulted in Resident 40
being served orange slices, cheese quesadilla, and pasta which had the potential to result in a
life-threatening condition such as anaphylactic shock (severe allergic reaction including closure of airways),
severe tachycardia (increased heart rate), cardiac arrest (sudden loss of heart function, breathing, and
consciousness [the state of being awake and aware of one's surroundings]), diarrhea, dehydration, low food
intake resulting to weight loss and/or death for Resident 40. Findings: During a review of Resident 40's
admission Record, the admission Record indicated the facility initially admitted Resident 40 on 5/10/2025
and readmitted on [DATE] with diagnoses that included chronic obstructive pulmonary disease (COPD, a
lung disease characterized by long term poor air flow to your lungs), pleural effusion (buildup of excess fluid
between the lung and chest wall) and chronic kidney disease (a condition in which the kidneys are
damaged and cannot filter through the heart in an emergency situation). During a review of Resident 40's
Minimum Data Sheet (MDS - a federally mandated resident assessment tool) dated 5/9/2025, the MDS
indicated Resident 40's understood others and made self understood. The MDS indicated Resident 40
needed supervision and touching assistance when eating (helper provides verbal cues and or
touching/steadying and/or contact guard assistance as a resident completes the activity. Assistance maybe
provided throughout the activity or intermittently). During a review of the facility's report titled Order Listing
Report dated 5/21/2025, the report indicated resident was on No Added Salt (NAS, a diet with no salt
packets on the tray), regular texture, thin consistency, offer vegetarian menu, no tomatoes, green leafy
vegetables, grapefruit and cranberry. During an interview on 6/30/2025 at 10 AM with Resident 40,
Resident 40 stated the food was inedible and she has lifelong allergies to blueberries, oranges, and
tomatoes and had been given tomato sauce on her tray from the kitchen. Resident 40 stated her tongue
swells up and she could not breathe as an allergic reaction. Resident 40 stated she gets gastroparesis and
could not have beef, chicken, ham, or lamb because her body could not break it down. During a review of
Resident 40's diet ticket dated 6/30/2025, the diet ticket indicated Resident 40 dislikes tomato products,
turkey, cranberry juice, olives, spinach, milk, broccoli, milk products, beef, chicken, ham, chocolate, pasta,
Brussel sprouts, and tofu. During a review of the facility's daily spreadsheet (a list of food, amount of food
that each diet would receive) titled Menus, dated 6/30/2025, the spreadsheet indicated residents on regular
diet (diet with no restriction) and CCHO would include the following foods on the tray: -Swedish meatballs
two (2) pieces -Gravy 1-2 ounces (oz, a unit of measurement) -Egg noodles 1/2 cup (c, a household
measurement) -Fresh zucchini and carrots 1/2 c -Orange slice 1 -Wheat rolls 1 pc -Margarine 1 teaspoon
-Raspberry parfait 2x2 1/2 inch (regular diet) -Diet gelatin with 1 tablespoon of whip cream (for CCHO diet)
-Milk 2 oz During an observation on 6/30/2025 at 12:35 p.m. of Resident 40's food tray, observed egg
noodles, quesadilla, carrots, zucchini, and orange slice on the plate. During a review of allergy report dated
7/1/2025, the allergy report indicated Resident 40 is allergic to eggs, olives, orange, tomato, and turkey
During an interview on 7/1/2025 at 10:23 a.m. with the Dietary Supervisor (DS), the DS stated the process
of catering food preferences and allergies upon resident's admission were as follows: 1.Introduce herself to
the residents and ask what their food preferences. 2.Ask for residents' likes
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 45 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0806
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
and dislikes 3.Ask for food allergies 4.Enter all the information on the computer to prepare the diet ticket
5.Diet tickets contain the residents' diet, diet consistency, beverages, special devices, dislikes, likes, dining
room information and which table they would be seated. 6.Enter food allergies on the right corner of the
ticket. During an interview on 7/1/2025 at 10:29 a.m. with the DS, the DS stated she was familiar with
Resident 40's food allergies and that he is allergic to beef, turkey, tuna, milk, orange products, peanut
butter, peanuts, vegetables. The DS stated Resident 40's diet ticket did not indicate food allergies, and she
received orange slice yesterday on her tray and it was not okay. The DS stated Resident 40 received pasta
and quesadilla which has milk product, and it was not okay as it was part of Resident 40's dislikes and
intolerances. The DS stated it was important to take note of Resident 40's allergies in the diet ticket
because of the Resident 40's at risk of being sick and resident could die as a potential outcome. During an
interview on 7/1/2025 at 10:40 a.m. with the DS, the DS stated there was a difference between dislikes and
food preferences and defined dislikes as foods residents did not want to eat. The DS further stated food
allergies is when a resident had certain reaction to food upon consumption. The DS stated the kitchen
should not be treating food allergies and food preferences the same for Resident 40 as she could have a
reaction to food she received on her tray even if it is an ingredient. The DS stated the right thing to do was
to enter the food allergies in the allergy section of the diet ticket rather than the dislike section. During an
interview on 7/1/2025 at 12:42 p.m. with Resident 40, Resident 40 stated she is allergic to beer, wine,
blueberries, tomatoes, papaya and oranges. Resident 40 she has intolerances when consuming milk and
milk products, whole grain breads, cheerios containing high fiber. Resident 40 stated he dislike bacon,
sausage, turkey, chicken. Resident 40 stated she did not take her tray yesterday because she cannot have
it and that kitchen staff were aware that she could not have certain food items, but they sent it anyway.
Resident 40 stated she felt that they did not care, and she got used to just not eating the food and order
from outside. During a review of the facility's Policies and Procedures (P&P) titled Food Allergies and
Intolerances dated 1/2025, the P&P indicated Residents with food allergies and/or intolerances are
identified upon admission and offered food substitutions of similar appeal and nutritional value. Steps are
taken to prevent resident exposure to the allergen(s). General Guidelines: 1.Food allergies are immune
system responses to allergens (foods). [NAME] antibodies to foods attach to mast cells in body tissue (e.g.,
skin, nose, throat, lungs, and gastrointestinal tract) and basophils in blood. When allergens are eaten, the
[NAME] antibodies attach to mast cells and basophils in certain sites and those cells produce histamine, an
anti-inflammatory compound. 2.Food Intolerances are unpleasant reactions to specific foods that are not life
threatening but can necessitate avoidance of triggering foods. For example, lactose intolerance is the
inability to digest milk sugars due to a deficiency in the enzyme lactase. Lactose intolerance causes gas,
bloating, cramping and diarrhea. Assessments and Interventions: (4) Meals for residents with severe food
allergies are specially prepared so that cross-contamination with allergies does not occur. (5) Residents
with food intolerances and allergies are offered appropriate substitutions for food that they cannot eat.
During a review of the facility's P&P titled Resident Food Preferences, dated 1/2025, the P&P indicated
Individual food preferences will be assessed upon admission and communicated to the interdisciplinary
team. Modifications to diet will only be offered with the residents' or representative's consent. Policy and
Interpretation: 1.Upon the resident's admission (or within twenty-four (24) hours after his/her admission) the
dietitian or nursing staff will identify a resident's food preferences. 2.When possible, staff will interview the
residents directly to determine current food preferences based on history and life patterns related to food
and mealtimes. 3.The food service
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 46 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0806
department will offer a variety of foods at each meal, as well as access to nourishing snacks throughout the
day and night.
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 47 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0808
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure therapeutic diets are prescribed by the attending physician and may be delegated to a registered or
licensed dietitian, to the extent allowed by State law.
Based on observation, interview and record review, the facility failed to ensure resident receive and
consume foods in the appropriate nutritive content as prescribed by a physician to support the resident
treatment and plan of care when one of two sampled resident (Resident 17) during a review of dining
observation task, who was on a fortified diet (a diet that includes foods with added nutrients, like vitamins
and minerals, that weren't naturally present in those foods) received fortified soup for lunches on 6/30/2025
and 7/1/2025. This deficient practice had the potential to cause weight loss for Resident 17. Findings:
During a review of Resident 17's admission Record (AR), the AR indicates the facility admitted Resident 17
on 8/11/2004 and readmitted the resident on 1/14/2021 with diagnoses including type two (2) diabetes
mellitus (DM2-a disorder characterized by difficulty in blood sugar control and poor wound healing),
gastroesophageal reflux disease (GERD- when stomach acid frequently flows back into the esophagus,
causing heartburn and other issues), and essential (primary) hypertension (HTN-high blood pressure).
During a review of Resident 17's Care plan created on 11/18/2024 and revised on 3/11/2025, the Care plan
for risk for altered nutritional status due to therapeutic diet with interventions that included dietary
supplements as ordered, provide substitutes per request and determine food preferences. During a review
of Resident 17's Minimum Data Set (MDS - a resident assessment tool) dated 4/9/2025, the MDS indicated
able to understand and able to be understood. The MDS indicated Resident 17 was independent
(completes the activity by themselves with no assistance from a helper) with eating, oral hygiene, toileting,
showering, upper body and lower body dressing, putting on and taking off footwear, and personal hygiene.
During a review of Resident 17's Care plan created on 4/9/2025, the Care plan for risk for dehydration and
malnutrition due to weight loss and poor oral intake with interventions that included encourage to take
supplements, give fortified soup for lunch and dinner and ice cream for lunch and dinner. During a review of
Resident 17's Order Summary Report (OSR) dated 4/7/2025, the OSR indicated mighty shake (a nutritional
shake designed to provide extra calories and protein) two times a day at lunch and dinner. During a review
of Resident 17's OSR dated 4/10/2025, the OSR indicated consistent carbohydrates (CCHO), no added
salt diet (NAS), regular texture, regular thin consistency, fortified soup for lunch and dinner, and add ice
cream for lunch and dinner. During a review of Resident 17's OSR dated 5/21/2025, the OSR indicated
Mirtazapine 15 milligrams (mg- a unit of measurement) by mouth at bedtime for depression mood behavior
poor oral intake less than 50 percent (%). During a review of Resident 17's IDT Conference Record Weight
Management dated 6/4/2025, the IDT indicated diet supplements as 4 ounces (oz- unit of measurement)
mighty shake chocolate at lunch and dinner, on ice cream, fortified soup, at lunch and dinner. During a
concurrent observation and interview on 6/30/2025 at 12:43 p.m. during the dining observation with
Resident 17, Resident 17 stated she likes rice and soup, and she was not given soup. During a concurrent
observation and interview on 7/1/2025 at 12:37 p.m. during the dining observation with Resident 17,
Resident 17 stated she received a grill cheese sandwich, shake, ice cream, mashed potatoes, Cesar salad,
spinach and dessert. Resident 17 stated she usually gets soup but did not get soup. During a concurrent
observation and interview on 7/1/2025 at 12:44 p.m. with Certified Nursing Assistant (CNA) 1, CNA 1 stated
there is no soup on Resident 17's tray. During a concurrent observation and interview on 7/1/2025 at 12:46
p.m. with Licensed Vocational Nurse (LVN) 1, LVN 1 stated there is no soup on Resident 17's tray. LVN 1
stated Resident 17 has an order to receive fortified soup, it is for added vitamins. LVN 1 stated if Resident
17 is not getting the fortified soup, Resident 17 can have a potential for a deficiency in vitamins. During an
interview on 7/1/2025 at 3:33 p.m. with the Dietary Supervisor
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 48 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0808
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
(DS), the DS stated fortified soup is for someone who is losing weight, so staff adds margarine, dry milk,
whole milk, and gravies, to add more calories to help with the weight gain. The DS stated if the resident is
ordered the fortified soup but is not given it can be a potential for Resident 17 to continue to lose weight.
During a review of the facility's Policy and Procedures (P&P) titled, Therapeutic Diets, last reviewed on
1/2025, the P&P indicated therapeutic diets are prescribed by the attending physician to support the
resident's treatment and plan of care and in accordance with his or her goals and preferences. 4. A
therapeutic diet is considered a diet ordered by a physician, practitioner or dietitian as part of treatment for
a disease or clinical condition, to modify specific nutrients in the diet, or alter the texture of the diet. During
a review of the facility's P&P titled, Fortification of Food: Increasing Calories and/or Protein in the Diet, last
reviewed on 1/2025, the P&P indicated the enrichment of foods will be done on an individual basis for the
resident who cannot consume adequate amounts of calories and/or protein to sustain their weight or
nutrition status. The goal is to increase the calories and/or protein density of the foods commonly
consumed by the residents to promote improvement in their nutrition status. Identification of the residents in
need of fortification will be done by the Dietitian or the FNS Director. The doctor will then order Fortified
Diet. Residents considered will have demonstrated an inability to consume the amounts of foods required to
prevent significant weight loss, skin breakdown, and/or loss of muscle mass. Calories and/or protein will be
added to selected foods. The Dietitian of FNS Director will select the fortification method from the list
provided for foods commonly or agreed upon to be consumed, or the RDs for Healthcare fortified guide will
be used. Any number of techniques may be chosen for a given resident. Adding protein/calories indicated
instant protein powder and instant calories/protein powders can be purchased. During a review of the
facility provided standardized recipe titled, Super Soup, reviewed on 1/2025, indicated the following
ingredients included soup and Multimix protein powder. Multimix adds 60 calories and 6 grams of protein
per 2 tablespoons.
Event ID:
Facility ID:
555132
If continuation sheet
Page 49 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0812
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Procure food from sources approved or considered satisfactory and store, prepare, distribute and serve
food in accordance with professional standards.
Based on observation, interview, and record review, the facility failed to ensure safe and sanitary food
storage and food preparation practices in the kitchen when: 1.Kitchen equipment and utensils were not
maintained in their proper condition, smooth and easy to clean. a. Vegetables reach-in freezer had ice
buildup. b. Reach-in freezer shelves by the preparation area were cracked and stained with amber
discoloration. c. Walk-in refrigerator blue shelves were cracked and chipped. 2.Four (4) of 4 cans were
stored with non-dented cans. 3.Kitchen equipment and kitchen areas were not cleaned and sanitized. a. Ice
machine internal parts had dry hard water buildup and black residues. b. The resident's refrigerator had
green dirt. 4.Staff did not perform hand hygiene when washing soiled dishes then cleaning and touching
clean resident's carts. These failures had the potential to result in harmful bacterial growth and cross
contamination (transfer of harmful bacteria from one place to another) that could lead to foodborne illness
(a disease caused by consuming food or drinks that are contaminated by germs or chemicals) in 64 of 69
medically compromised residents who received food and ice from the kitchen. Findings: 1.a. During an
observation on 6/30/2025 at 8:36 a.m. of the reach-in freezer, observed ice buildup by the door and shelves
of the reach-in freezer. During an interview on 6/30/2025 at 8:47 a.m. with the Dietary Supervisor (DS), the
DS stated there was an issue with the freezer and it was producing a lot of ice buildup. The DS stated they
installed a metal plate so the inside freezer air would not go out. The DS stated the cause of the ice buildup
was the air coming in from the outside and it builds condensation causing ice-buildup. The DS stated there
was still a small gap in the freezer and it was not okay as the food could spoil if the air from the outside was
coming in. The DS stated residents could get sick of stomachache, and the quality of food and freshness
would be affected. During a review of the facility's Policy and Procedure (P&P) titled Sanitation dated
1/2025, the P&P indicated, POLICY: The Food and Nutrition Services Department shall have equipment of
the type and, in the amount, necessary for the proper preparation, serving and storing of food. (4)
Employees are to alert the FNS Director immediately to any equipment needing repair. (5) The FNS
Director (an/or cook in his absence) will report any equipment needing repair to the maintenance man. (6)
The maintenance department will assist Food and Nutrition Service as necessary in maintaining equipment
and in doing janitorial duties which the Food and Nutrition employees cannot do and maintain maintenance
records on all equipment. b. During an observation on 6/30/2025 at 8:40 a.m. of the meat freezer by the
preparation area, observed the shelves were cracked with amber discoloration. During concurrent
observation and interview on 6/30/2025 at 8:55 a.m. of the meat freezer with the DS, the DS stated the
freezer shelves were not in good condition as they were broken, cracked, a had yellowish discoloration and
needed to be replaced. The DS stated the stain did not come off and it was not okay as it could grow
bacteria in the cracks of the shelves. The DS stated the residents could get sick of stomachache and crack
shelves could be a potential hazard for the food of the residents. c. During an observation on 6/30/2025 at
9:04 a.m. of the walk-in refrigerator racks, observed two (2) of 2 racks were chipped and not smooth. During
an interview on 6/30/2025 at 9:11 a.m. with the DS, the DS stated the racks in the walk-in refrigerator were
cracked and not smooth and it was the same problem with the shelves in the freezer. The DS stated
bacteria could grow in the cracks of the racks and could contaminate food. The DS stated resident could get
sick as a potential outcome. During a review of the facility's P&P titled, Refrigerator and Freezer, dated
1/2025, the P&P indicated, (9) Periodically inspect shelves and replace if coating is chipped away exposing
metal shelves. During a review of Food Code 2022, dated 1/18/2023, the Food Code 2022 indicated,
4-202.11 Food-Contact Surfaces. (A) Multiuse Food-contact
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 50 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0812
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
surfaces shall be (1) Smooth (2) Free of breaks, open seams, cracks, chips, inclusions, pits, and similar
imperfections. (3) Free of sharp internal angles, corners, and crevices, (4) Finished to have smooth welds
and joints. During a review of Food Code 2022, dated 1/18/2023 the Food Code 2022 indicated, 3-307.11
Miscellaneous Sources of Contamination. Food shall be protected from contamination that may result from
a factor or source not specified under subparts 3-391 - 3-306. 2.During a concurrent observation and
interview on 6/30/2025 at 9:15 a.m. of the dry storage area, observed 4 of 4 dented cans stored with
non-dented cans. The DS stated they have a designated dented cans area so their staff would not use it.
The DS stated the dented cans were smashed and it was dangerous for residents' consumption and the
residents could die upon consumption of food from the dented cans as a potential outcome. During a
review of the facility's P&P titled, Food Storage-Dented Cans, dated 1/2025, the P&P indicated, Food in
unlabeled, rusty, leaking, broken containers or cans with side seam dents, rim dents or swells shall not be
retained or used by the facility. Procedure: All dented cans (defined as side seam or rim dents) and rusty
cans are to be separated from retaining stock and placed in a specified labeled area for return to purveyor
for refund. All leaking cans are to be disposed of immediately. During a review of Food Code 2022, dated
1/18/2023, the Food Code 2022 indicated, 3-101.11 Safe Unadulterated, and Honestly Presented. Food
shall be safe, unadulterated, and, as specified under 3-601.12, honestly presented. 3-201.11 Compliance
with Food Law. A primary line of defense ensuring that food meets the requirements of S3-101.11 is to
obtain food from approved sources, the implications of which are discussed below. However, it is also
critical to monitor food products to ensure that, after harvesting, processing, they do not fail victims to
conditions that endanger their safety, make them adulterated, or compromise their honest presentation. The
regulatory community, industry, and consumers should exercise vigilance in controlling the conditions to
which foods are subjected and be alert to signs of abuse. FDA considers food in hermetically sealed
containers that are swelled or leaking to be adulterated and actionable under the Federal Food, Drug, and
Cosmetic Act. Depending on the circumstances, rusted, and pitted or dented cans may also present a
serious potential hazard. 3.a. During an observation on 6/30/2025 at 11:09 a.m., of the ice machine, white
dirt particles observed inside the ice machine. During a concurrent observation and interview on 6/30/2025
at 11:13 p.m. with the DS, observed the ice machine internal parts had white and black dirt particles. The
DS stated the last time the outside company cleaned the ice machine was on 6/11/2025. However, the
white particles were hard water buildup and there was also black dirt when wiped using a paper towel. The
DS stated it was not okay to have dirt in the ice machine because was it would turn into mold so the ice bin
would have to be emptied, and the ice would be thrown out. The DS stated the bacteria could grow on ice
and residents could get sick upon ice consumption as a potential outcome. During a review of the facility's
P&P titled, Ice Machine Cleaning Procedures, dated 1/2025, the P&P indicated Policy: The ice machine
needs to be cleaned and sanitized monthly. The internal components cleaned monthly or per manufacturer
recommendations, and the date recorded when cleaned. During a review of the facility's manufacturer's
guidelines of the ice machine titled, Maintenance, undated, the guidelines indicated, Clean and sanitize the
ice machine every six months for efficient operation. If ice machines require more frequent cleaning and
sanitizing, consult a qualified service company to test the water quality and recommend appropriate water
treatment. An extremely must be taken apart for cleaning and sanitizing. b. During a concurrent observation
and interview on 7/1/2025 at 10:45 a.m. of the resident's refrigerator inside the staff lounge with the DS, the
DS stated the green dirt looked like paint and it needed to be cleaned as residents could get sick due to
cross-contamination. During a review of the facility's P&P titled, Refrigerator and Freezer, dated 1/2025,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 51 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0812
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
the P&P indicated, Maintaining a clean refrigerator and freezer can improve the safety and quality of your
foods. During a review of Food Code 2022, dated 1/18/2023, the Food Code 2022 indicated, 4-601.11 (A)
Equipment Food Contact Surfaces and utensils shall be cleaned: (1) Except as specified in (B) of this
section, before use with a different type of raw animal food such as beef, fish, lamb, pork or poultry; (2)
Each time there is a change from working with raw foods to working with ready-to-eat food; (3) Between
uses with raw fruits and vegetables and with time/temperature control for safety food. (4) Before using or
storing a food temperature measuring device, and (5) At the time during the operation when contamination
may have occurred. During a review of Food Code 2022, dated 1/18/2023, the Food Code 2022
indicated,4-602.13 Nonfood-Contact Surfaces. Nonfood-contact surfaces of equipment shall be cleaned at
a frequency necessary to preclude accumulation of soil residues. 4.During a concurrent observation and
interview on 7/1/2025 at 10 a.m. during the dishwashing process with Dietary Aide 1 (DA 1), observed DA 1
loaded the rack with the soiled dishes then proceeded to clean the carts using the sanitizer then touched
the clean carts without changing her gloves. DA 1 stated the dishwashing area was dirty and the cart was
clean, and she should have changed her gloves or washed her hands to prevent dirt from the soiled dishes
to the clean carts. During an interview on 7/1/2025 at 10:06 a.m. with the DS, the DS stated handwashing
must be done every time a staff member finished a task and when changing task to avoid
cross-contamination. The DS stated DA 1 should have washed her hands because she worked from the
dirty dishes then going to a clean surface. The DS stated residents could get sick due to cross
contamination as a potential outcome. During a review of the facility's P&P titled, Handwashing/Hand
Hygiene, dated 1/2025, the P&P indicated This facility considers hand hygiene the primary means to
prevent the spread of infection. (7) Use an alcohol-based hand rub containing at least 62% alcohol; or,
alternatively, soap (antimicrobial or non-antimicrobial) and water for the following situations. (g) before
handling clean or soiled dressings, gauze pads, etc. During a review of Food Code 2022, dated 1/18/2023,
the Food Code indicated 2-301.14 When to Wash. FOOD EMPLOYEES shall clean their hands and
exposed portions of their arms as specified under S 2-301.12 immediately before engaging in FOOD
preparation including working with exposed FOOD, clean EQUIPMENT and UTENSILS, and unwrapped
SINGLE-SERVICE and SINGLE-USE ARTICLESP and: (A) After touching bare human body parts other
than clean hands and clean, exposed portions of arms; P (B) After using the toilet room; P (C) After caring
for or handling SERVICE ANIMALS or aquatic animals as specified in 2-403.11(B); P (D) Except as
specified in 2-401.11(B), after coughing, sneezing, using a handkerchief or disposable tissue, using
TOBACCO PRODUCTS, eating, or drinking; P (E) After handling soiled EQUIPMENT or UTENSILS; P (F)
During FOOD preparation, as often as necessary to remove soil and contamination and to prevent cross
contamination when changing tasks; P (G) When switching between working with raw FOOD and working
with READY-TO-EAT FOOD; P (H) Before donning gloves to initiate a task that involves working with
FOOD; P and (I) After engaging in other activities that contaminate the hands.
Event ID:
Facility ID:
555132
If continuation sheet
Page 52 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Provide and implement an infection prevention and control program.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review, the facility failed to maintain an infection prevention
and control program designed to provide a safe, sanitary, and comfortable environment and to help prevent
the development and transmission of communicable diseases and infections by failing to: 1. Ensure the
indwelling urinary catheter (a flexible tube placed in the bladder to drain urine) drainage bag (a urine
collection bag connected to the catheter) was maintained off the floor for one of one sampled residents
(Resident 20) reviewed during the Urinary Catheter or Urinary Tract Infections (UTI, an infection in the
bladder/urinary tract) care area. This deficient practice had the potential to spread infections and illnesses
among residents and staff. 2. Ensure food items were not left inside the clean linen storage. This deficient
practice had the potential to result in infection risk and cross-contamination. Findings: a. During a review of
Resident 20’s admission Record (AR), the AR indicated the facility originally admitted the resident
on 3/17/2025 and most recently re-admitted the resident on 5/1/2025 with diagnoses that included end
stage renal disease (ESRD -irreversible kidney failure), type two diabetes mellitus (DM-a disorder
characterized by difficulty in blood sugar control and poor wound healing), unspecified dementia (a general
term for loss of memory, language, problem-solving and other thinking abilities that interfere with daily life),
and sepsis (a life-threatening blood infection).
Residents Affected - Few
During a review of Resident 20’s Minimum Data Set (MDS – resident assessment tool),
dated 6/6/2025, the MDS indicated the resident was able to understand others and was able to make
himself understood. The MDS further indicated Resident 20 was dependent on staff for eating, bathing,
dressing, toileting, personal and oral hygiene, and transferring from the bed to chair.
During a review of Resident 20’s Order Summary Report, the Order Summary Report indicated a
physician’s order for the following:
-Catheter, may change indwelling catheter drainage bag if leaking or disconnected as needed for indwelling
catheter care, dated 6/18/2025.
-Catheter care every shift, dated 6/18/2025.
During a review of Resident 20’s Care Plan (CP) regarding the indwelling urinary catheter, initiated
6/19/2025, the CP indicated interventions to use proper precaution for infection control and to use proper
handwashing technique at all times.
During a concurrent observation and interview on 6/30/2025 at 10:15 a.m., observed Resident 20 lying in
bed. Observed an indwelling urinary catheter drainage bag hanging off the right side of the bed frame.
Observed the drainage bag was resting on the floor. Observed Licensed Vocational Nurse (LVN) 3 entered
Resident 20’s room and assessed the drainage bag and stated the drainage bag was on the floor.
LVN 3 stated it was not okay for the drainage bag to be on the floor because bacteria can get on the bag
from the floor, travel up the tubing to the resident’s urethra (part of the body that transmits urine
from the bladder to the exterior of the body during urination), and cause an infection. Observed LVN 3
raised the resident’s bed, and the drainage bag no longer touched the floor.
During a concurrent observation and interview on 7/2/2025 at 11:45 a.m. with LVN 3, LVN 3 entered
Resident 20’s room to perform indwelling catheter care. Observed Resident 20’s indwelling
catheter drainage bag resting on the floor. LVN 3 stated that when the resident’s bed is all
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 53 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
the way down, the catheter drainage bag rests on the floor, so the bed should not be in the very lowest
position, but it was, and the drainage bag was on the ground. LVN 3 stated facility staff are educated to
keep the drainage bags off the floor.
During a concurrent interview and record review on 7/2/2025 at 1:40 p.m. with Registered Nurse (RN) 1,
RN 1 reviewed the facility Policy and Procedure (P&P) regarding indwelling catheters and infection control.
RN 1 stated catheter drainage bags should not be on the ground because it is an infection control risk. RN
1 stated the bed must be kept high enough to keep the drainage bag off the ground to keep bacteria from
entering the resident’s body and potentially resulting in an infection. RN 1 stated when Resident
20’s indwelling catheter drainage bag was on the ground, the facility P&P was not followed.
During a review of the facility provided Procedure titled, “Catheter-Care, Urinary,” last
reviewed 1/2025, the Procedure indicated the purpose of this procedure is to prevent catheter-associated
urinary tract infections. Maintain clean technique when handling or manipulating the catheter, tubing, or
drainage bag. Be sure the catheter tubing and drainage bag are kept off the floor. Observe for other signs
and symptoms of urinary tract infection or urinary retention.
During a review of the facility provided P&P titled, “Infection Control Guidelines for All Nursing
Procedures,” last reviewed 1/2025, the P&P indicated the purpose was to provide guidelines for
general infection control while caring for residents. Prior to having direct-care responsibilities for residents,
staff must have appropriate in-service training on general infection and exposure control issues.
b. During a concurrent observation and interview on 7/3/2025 at 9:24 a.m. with the Maintenance Supervisor
(MS), inside the clean linen closet, the MS stated they store the clean linens, beddings, towels, gowns, and
residents' personal clothes when their vendor delivers them, and they store it here in the clean linen closet.
The MS stated there is a bagel, a banana, and a bottle of Gatorade (a sports drink). The MS stated these
items belong to his assistant. The MS stated he has already told his assistant not to store food items in the
clean linen closet because it is to be kept clean.
During an interview on 7/3/2025 at 12:28 p.m. with the DON, the DON stated the food items should not be
stored in the clean linen storage. The DON stated it invites insects and would not be sanitary to be kept
there, and residents’ clothes would be infected.
During a review of the facility’s policy and procedure (P&P) titled, “Storage Areas,
Environmental Services,” last reviewed 1/2025, the P&P indicated that housekeeping and laundry
department storage areas shall be maintained in a clean and safe manner. The P&P indicated all
housekeeping and laundry storage areas shall be kept free from accumulation of trash, rubbish, oily, rags,
paper, etc., at all times.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 54 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0908
Keep all essential equipment working safely.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review the facility failed to ensure the reach-in freezer was
maintained according to manufacturer's guidelines where there was a gap causing air to come in the reach
in freezer resulting in ice buildup of 1 of 2 reach-in freezer. This deficient practice had the potential to result
in danger zone temperatures (a range of temperatures in which food-borne bacteria could grow) that could
lead to foodborne illness (illness caused by food contaminated with bacteria, viruses, parasites, or toxins) in
64 of 69 medically compromised residents who stored food in the resident's refrigerator and freezer.
Findings: During an observation on 6/30/2025 at 8:36 a.m. of the reach-in freezer, observed ice buildup by
the door and shelves of the reach-in freezer. During an interview on 6/30/2025 at 8:47 a.m. with the Dietary
Supervisor (DS), the DS stated there was an issue with the freezer and it was producing a lot of ice buildup.
The DS stated they installed a metal plate so the inside freezer air would not go out. The DS stated the
cause of ice buildup was the air coming in from the outside and it builds condensation causing ice-buildup.
The DS stated there was still a small gap in the freezer and it was not okay as the food could spoil if the air
from the outside is coming in. The DS stated residents could get sick of stomachache, and the quality of
food and freshness would be affected. During an interview on 7/1/2025 at 1:53 p.m. with the Maintenance
Supervisor (MS), the MS stated that they had an issue with the kitchen reach-in freezer with the air from
the outside was coming in the freezer. MS stated the freezer door would not stick well and he was
supposed to change the gaskets. However, the administrator decided to place a metal plate between the
door so it could close properly and there would not be hot air coming in. The MS stated it was the
administrator's decision to do it. During an interview on 7/1/2025 at 2:02 p.m. with the Administrator (ADM),
the ADM stated there was an issue with the reach in freezer in the kitchen as it was not latching properly
and he discussed it with the MS and decided to buy a metal and install it so there would not be defrosting
happening. The ADM stated they did not call the manufacturer to check for the solution. ADM stated he was
not aware that there was still an issue of ice-buildup. During a review of the facility's Policy and Procedure
(P&P) titled, Sanitation, dated 1/2025, the P&P indicated, POLICY: The Food and Nutrition Services
Department shall have equipment of the type and, in the amount, necessary for the proper preparation,
serving and storing of food. (4) Employees are to alert the FNS Director immediately to any equipment
needing repair. (5) The FNS Director (an/or cook in his absence) will report any equipment needing repair
to the maintenance man. (6) The maintenance department will assist Food and Nutrition Service as
necessary in maintaining equipment and in doing janitorial duties which the Food and Nutrition employees
cannot do and maintain maintenance records on all equipment. During a review of the facility's log titled,
Daily Maintenance Communication Log, dated 4/1/2025, the log indicated, maintenance department was
aware of the freezer was still having issues of ice buildup around the door.
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 55 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0912
Level of Harm - Potential for
minimal harm
Residents Affected - Some
Provide rooms that are at least 80 square feet per resident in multiple rooms and 100 square feet for single
resident rooms.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to provide at least 80 square feet (sq. ft. - a unit
of measurement) per resident in multiple resident bedrooms for 24 of 24 resident rooms (Rooms 1, 2, 3, 4,
5, 6, 7, 8, 10, 11, 12, 14, 15, 16, 17, 19, 20, 21, 22, 23, 24, 25, 26, and 27). This deficient practice had the
potential to result in inadequate useable living space for all the residents and working space for the health
caregivers, which could affect the safety and quality of life for the residents. Findings: During a concurrent
observation and interview on 6/30/2025 at 9:10 a.m., Resident 50 sleeping in bed, wheelchair at the end of
bed with space for movement for staff and residents. Certified Nursing Assistant (CNA) 9 stated Resident
50 goes to dialysis every Tuesday, Thursday, and Saturday and had no concerns with the space in the
rooms. During an interview on 6/30/2025 at 10:45 a.m. with Resident 50, Resident 50 stated has no
concerns with space in the room. During a concurrent observation and interview on 6/30/2025 at 9:20 a.m.,
inside room [ROOM NUMBER], three beds in the room and bed B with an oversized bed with ample space
for movement of residents. Resident 56 stated he had no issues with the room space. During an
observation on 6/30/2025 at 10:15 a.m., inside room [ROOM NUMBER], Resident 42 in the room, sitting up
in wheelchair and able to self-propel past bed A and bed B with Resident 20 lying in bed with no concerns
identified regarding space in the room. During an interview on 7/2/2025 at 1:14 p.m. with CNA 5, CNA 5
stated was assigned to rooms 20, 22, 5C, and 6A and had provided showers to three residents today. CNA
5 stated she had enough space to provide care, 22B likes to move the table and 6A can move beds and
roommates bed able to move, and she puts it back after. During an interview on 7/2/2025 at 1:21 p.m. with
CNA 6, CNA 6 stated she was assigned to rooms [ROOM NUMBER]C. CNA 6 stated she had enough
room to provide care. CNA 6 stated 26B requires a lift machine and she has enough space to maneuver the
machine. During an interview on 7/2/2025 at 1:40 p.m. with Registered Nurse (RN) 1, RN 1 stated she
assist with care with CNAs such as pulling a resident up in bed or refusing to shower and talk to the
resident and inform that responsibility and getting what they need. RN 1 stated she has enough space to
provide care to the residents and has no concerns with the space. During a concurrent interview and record
review on 7/3/2025 at 8:56 a.m., reviewed facility's room waiver letter, dated 6/30/2025, the Director of
Nursing (DON) stated the room waiver request is for rooms 1, 2, 3, 4, 5, 6, 7, 8, 10, 11, 12, 14, 15, 16, 17,
19, 20, 21, 22, 23, 24, 25, 26, and 27, for a total of 24 rooms. The DON stated the request for a waiver does
not meet the required 80 sq. ft. per resident in multiple bedrooms. The DON stated their policy is 80 sq ft for
double rooms. During a review of the facility's room waiver letter request, dated 6/30/2025, the letter
indicated that the rooms slightly fall short of the minimum square footage requirement, but the needs of the
residents are fully accommodated. The residents are able to move about the room freely; bathrooms and
closets are easily accessible and all required furniture is provided for each resident. Delivery of care is
unimpeded in any way. Furthermore, the residents can be quickly and safely evacuated in the event of
emergency. The rooms are in accordance with the special needs of the residents and would not have an
adverse effect on the resident's health and safety or impede the ability of any of the residents in the rooms
to attain his or her highest practicable wellbeing. The letter indicated the following measurements in square
footage for the residents' rooms: - room [ROOM NUMBER]: 229.1 sq. ft., three beds, 19.87 feet by 11.54
feet - room [ROOM NUMBER]: 229.1 sq. ft., three beds, 19.87 feet by 11.54 feet - room [ROOM NUMBER]:
229.1 sq. ft., three beds, 19.87 feet by 11.54 feet - room [ROOM NUMBER]: 229.1 sq. ft., three beds, 19.87
feet by 11.54 feet - room [ROOM NUMBER]: 229.1 sq. ft., three beds, 19.87 feet by 11.54 feet - room
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 56 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0912
Level of Harm - Potential for
minimal harm
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
[ROOM NUMBER]: 229.1 sq. ft., three beds, 19.87 feet by 11.54 feet - room [ROOM NUMBER]: 223.25 sq.
ft., three beds, 19.10 feet by 11.9 feet - room [ROOM NUMBER]: 229.1 sq. ft., three beds, 19.87 feet by
11.54 feet - room [ROOM NUMBER]: 230.8 sq. ft., three beds, 19.9 feet by 11.6 feet - room [ROOM
NUMBER]: 230.8 sq. ft., three beds, 19.9 feet by 11.6 feet - room [ROOM NUMBER]: 230.8 sq. ft., three
beds, 19.9 feet by 11.6 feet - room [ROOM NUMBER]: 230.8 sq. ft., three beds, 19.9 feet by 11.6 feet room [ROOM NUMBER]: 230.8 sq. ft., three beds, 19.9 feet by 11.5 feet - room [ROOM NUMBER]: 230.8
sq. ft., three beds, 19.9 feet by 11.6 feet - room [ROOM NUMBER]: 230.8 sq. ft., three beds, 19.9 feet by
11.6 feet - room [ROOM NUMBER]: 230.8 sq. ft., three beds, 19.9 feet by 11.6 feet - room [ROOM
NUMBER]: 230.8 sq. ft., three beds, 19.9 feet by 11.6 feet - room [ROOM NUMBER]: 227.3 sq. ft., three
beds, 19.6 feet by 11.6 feet - room [ROOM NUMBER]: 233.04 sq. ft., three beds, 19.10 feet by 11.5 feet room [ROOM NUMBER]: 227.3 sq. ft., three beds, 19.6 feet by 11.6 feet - room [ROOM NUMBER]: 228.8
sq. ft., three beds, 19.9 feet by 11.5 feet - room [ROOM NUMBER]: 227.3 sq. ft., three beds, 19.6 feet by
11.5 feet - room [ROOM NUMBER]: 228.8 sq. ft., three beds, 19.9 feet by 11.5 feet - room [ROOM
NUMBER]: 226.53 sq. ft., three beds, 19.6 feet by 11.6 feet During a review of the facility's policy and
procedure titled, Bedrooms, last reviewed 1/2025, the P&P indicated that all residents are provided with
clean, comfortable, and safe bedrooms that meet federal and state requirements. The P&P indicated that
bedrooms accommodate no more than two residents at a time. The P&P indicated bedrooms measure at
least 80 square feet of space per resident in double rooms, and at least 100 square feet of space in single
rooms. The P&P indicated Note: Individual variations on this may be permitted by federal authorities if it is
demonstrated that the variation is in accordance with special needs of the resident and will not adversely
affect the resident's health and safety.
Event ID:
Facility ID:
555132
If continuation sheet
Page 57 of 58
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555132
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
07/03/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Valley Vista Nursing and Transitional Care LLC
6120 N. Vineland Ave
North Hollywood, CA 91606
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0925
Make sure there is a pest control program to prevent/deal with mice, insects, or other pests.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review, the facility failed to maintain sanitary conditions in the
food services department when four (4) flies (a type of insect) were observed in the kitchen during trayline
(an area where foods were assembled from the steamtable to resident's plate). This failure had the potential
to result in 64 of 69 residents, who received food from the kitchen, to acquire food borne illnesses (illness
caused by consuming contaminated foods or beverages) by consuming potentially contaminated food.
Findings: During a concurrent observation and interview on 6/30/2025 at 12:43 p.m. with the Dietary
Supervisor (DS), two (2) flies were flying around the trayline area and landed on the pan. The DS stated the
flies probably came in from the outside when the staff opened the door and they needed to place a fly
curtain to avoid flies from coming in the kitchen when they open the door. During an observation on
6/30/2025 at 12:58 p.m., observed one (1) fly landed on the blender. During an interview on 6/30/2025 at
1:12 p.m. with the DS, the DS stated there were flies flying around the kitchen because it came in when the
staff brought the ice and it was important to have a kitchen free from flies to avoid cross-contamination of
food. The DS stated flies could bring bacteria to food and residents could get sick of stomach issues as a
potential outcome of consuming contaminated food. During a concurrent observation and interview on
7/1/2025 at 10:40 a.m. with the DS in the preparation area, observed one fly flying around the preparation
area by the preparation sink. The DS stated they needed to have a fly-free kitchen to prevent
cross-contamination. During a review of facility's policies and procedures (P&P) titled, Pest Control,
reviewed 1/2025, the P&P indicated, Our facility shall maintain an effective pest control program. (1) This
facility maintains an on-going pest control program to ensure that the building is kept free of insects and
rodents. During a review of Food Code 2022, dated 1/18/2023, the Food Code 2022 indicated 6.501.111
Controlling Pests. The premises shall be maintained free of insects, rodents and other pests shall be
controlled to eliminate their presence on the premises by: a. Routinely inspecting incoming shipments of
food and supplies. b. Routinely inspecting the premises for evidence of pests. c. Using methods, if pests are
found, such as trapping devices or other means of pest control specified under SS 7-202.12, 7-206.12, and
7-206.13. d. Eliminating harborage conditions.
Residents Affected - Some
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555132
If continuation sheet
Page 58 of 58